Trulieve Cannabis (TCNNF) 10-Q 9 Aug 23 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 03, 2023
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Registrant Name	TRULIEVE CANNABIS CORP.
Entity Central Index Key	0001754195
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-56248
Entity Incorporation, State or Country Code	A1
Entity Tax Identification Number	84-2231905
Entity Address, Address Line One	6749 Ben Bostic Road
Entity Address, City or Town	Quincy
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32351
City Area Code	850
Local Phone Number	298-8866
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Subordinate Voting Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		159,761,126
Multiple Voting Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		26,226,386

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 152,369	$ 207,185
Restricted cash	7,575	6,607
Accounts receivable, net	7,013	6,507
Inventories, net	252,785	276,505
Prepaid expenses and other current assets	42,867	62,278
Notes receivable - current portion	754	728
Assets associated with discontinued operations	11,474	33,701
Total current assets	474,837	593,511
Property and equipment, net	708,655	743,260
Right of use assets - operating, net	98,654	99,610
Right of use assets - finance, net	62,876	70,495
Intangible assets, net	951,460	984,797
Goodwill	483,905	791,495
Notes receivable, net	11,855	11,992
Other assets	14,427	12,768
Long term assets associated with discontinued operations	2,013	92,445
TOTAL ASSETS	2,808,682	3,400,373
Current Liabilities:
Accounts payable and accrued liabilities	75,457	82,090
Income tax payable	0	49,790
Deferred revenue	5,784	9,393
Notes payable - current portion	9,076	12,453
Private placement notes - current portion, net	125,861	0
Operating lease liabilities - current portion	9,668	10,344
Finance lease liabilities - current portion	7,595	8,271
Construction finance liabilities - current portion	1,324	1,189
Contingencies	2,411	34,666
Liabilities associated with discontinued operations	3,411	2,274
Total current liabilities	240,587	210,470
Long-term liabilities:
Notes payable, net	92,958	94,247
Private placement notes, net	418,605	541,664
Warrant liabilities	0	252
Operating lease liabilities	100,731	100,531
Finance lease liabilities	64,616	69,948
Construction finance liabilities	136,939	137,144
Deferred tax liabilities	211,901	224,696
Other long-term liabilities	37,424	26,027
Long term liabilities associated with discontinued operations	42,908	67,690
TOTAL LIABILITIES	1,346,669	1,472,669
Commitments and contingencies (see Note 20)
SHAREHOLDERS' EQUITY
Additional paid-in-capital	2,047,879	2,045,003
Accumulated deficit	(581,816)	(113,843)
Non-controlling interest	(4,050)	(3,456)
TOTAL SHAREHOLDERS' EQUITY	1,462,013	1,927,704
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 2,808,682	$ 3,400,373

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Common stock, no par value
Common stock, shares authorized, unlimited [Fixed List]	Unlimited	Unlimited
Common stock, shares issued	185,987,512	185,987,512
Common stock, shares outstanding	185,987,512	185,987,512

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue, net	$ 281,795	$ 313,839	$ 567,009	$ 624,400
Cost of goods sold	140,188	130,466	275,240	261,172
Gross profit	141,607	183,373	291,769	363,228
Expenses:
Sales and marketing	61,075	73,902	121,808	145,352
General and administrative	34,902	33,575	74,212	66,989
Depreciation and amortization	26,052	29,367	55,666	57,151
Impairments and disposals of long-lived assets, net	3,310	5,055	6,689	21,516
Impairment of goodwill	307,590	0	307,590	0
Total expenses	432,929	141,899	565,965	291,008
(Loss) income from operations	(291,322)	41,474	(274,196)	72,220
Other (expense) income:
Interest expense	(18,931)	(18,144)	(40,091)	(34,497)
Change in fair value of derivative liabilities - warrants	0	1,442	252	2,262
Other income, net	1,976	1,683	6,893	2,568
Total other expense, net	(16,955)	(15,019)	(32,946)	(29,667)
(Loss) income before provision for income taxes	(308,277)	26,455	(307,142)	42,553
Provision for income taxes	34,027	45,242	69,484	88,384
Net loss from continuing operations	(342,304)	(18,787)	(376,626)	(45,831)
Net loss from discontinued operations, net of tax (provision) benefit of $(946), $473, $(439), and $1,299, respectively	(64,568)	(5,234)	(95,877)	(10,672)
Net loss	(406,872)	(24,021)	(472,503)	(56,503)
Less: Net loss attributable to non-controlling interest from continuing operations	(2,353)	(1,530)	(3,337)	(2,037)
Less: Net loss attributable to non-controlling interest from discontinued operations	(670)	0	(1,193)	0
Net loss attributable to common shareholders	$ (403,849)	$ (22,491)	$ (467,973)	$ (54,466)
Net loss per share - Continuing operations:
Basic	$ (1.8)	$ (0.09)	$ (1.98)	$ (0.23)
Diluted	(1.8)	(0.09)	(1.98)	(0.23)
Net loss per share - Discontinued operations:
Basic	(0.34)	(0.03)	(0.5)	(0.06)
Diluted	$ (0.34)	$ (0.03)	$ (0.5)	$ (0.06)
Weighted average number of common shares used in computing net loss per share:
Basic	189,054,359	187,174,176	188,976,834	187,124,886
Diluted	189,054,359	187,174,176	188,976,834	187,124,886

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net (income) loss from discontinued operations, net of tax (provision)	$ (946)	$ 473	$ (439)	$ 1,299

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Multiple Voting Shares	Subordinate Voting Shares	Subordinate Voting Shares PurePenn, Pioneer, Solevo	Common Shares	Common Shares PurePenn, Pioneer, Solevo	Additional Paid-in-Capital	Accumulated (Deficit) Earnings	Non-Controlling Interest
Beginning Balance at Dec. 31, 2021	$ 2,147,373						$ 2,008,100	$ 137,721	$ 1,552
Beginning Balance (in shares) at Dec. 31, 2021		51,916,999	128,587,173		180,504,172
Share-based compensation	4,564						4,564
Exercise of stock options	108						108
Exercise of stock options (in shares)			45,775		45,775
Shares issued for cash - warrant exercise	22						22
Shares issued for cash - warrant exercise (in shares)			1,648		1,648
Shares issued under share compensation plans (in shares)			16,257		16,257
Tax withholding related to net share settlement of equity awards	(230)						(230)
Tax withholding related to net share settlement of equity awards (in shares)			(10,005)		(10,005)
Conversion of Multiple Voting to Subordinate Voting Shares		(2,699,100)	2,699,100
Shares issued for PurePenn, Pioneer, and Solevo earnouts (in shares)				3,626,295		3,626,295
Distribution	(50)								(50)
Divestment of variable interest entity	(111)								(111)
Net loss	(32,482)							(31,975)	(507)
Ending Balance at Mar. 31, 2022	2,119,194						2,012,564	105,746	(884)
Ending Balance (in shares) at Mar. 31, 2022		49,217,899	134,966,243		184,184,142
Share-based compensation	5,703						5,703
Exercise of stock options (in shares)			2,997		2,997
Shares issued for cash - warrant exercise	19,216						19,216
Shares issued for cash - warrant exercise (in shares)			1,426,614		1,426,614
Subordinate Voting Shares issued under share compensation plans (in shares)			24,444		24,444
Conversion of Multiple Voting to Subordinate Voting Shares		(13,091,800)	13,091,800
Net loss	(24,021)							(22,491)	(1,530)
Ending Balance at Jun. 30, 2022	2,120,092						2,037,483	83,255	(646)
Ending Balance (in shares) at Jun. 30, 2022		36,126,099	149,512,098		185,638,197
Beginning Balance at Dec. 31, 2022	1,927,704						2,045,003	(113,843)	(3,456)
Beginning Balance (in shares) at Dec. 31, 2022		26,226,386	159,761,126		185,987,512
Share-based compensation	2,401						2,401
Distribution	(50)								(50)
Value of shares earned for purchase of variable interest entity	1,643						1,643
Net loss	(65,631)							(64,124)	(1,507)
Ending Balance at Mar. 31, 2023	1,866,067						2,049,047	(177,967)	(5,013)
Ending Balance (in shares) at Mar. 31, 2023		26,226,386	159,761,126		185,987,512
Share-based compensation	475						475
Termination of purchase of variable interest entity	(1,643)						(1,643)
Deconsolidation and divestment of variable interest entities	3,986								3,986
Net loss	(406,872)							(403,849)	(3,023)
Ending Balance at Jun. 30, 2023	$ 1,462,013						$ 2,047,879	$ (581,816)	$ (4,050)
Ending Balance (in shares) at Jun. 30, 2023		26,226,386	159,761,126		185,987,512

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flow from operating activities
Net loss	$ (472,503)	$ (56,503)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	56,610	60,194
Depreciation included in cost of goods sold	30,945	24,501
Non-cash interest expense, net	2,794	2,353
Impairment and disposal of long-lived assets, net	6,689	21,516
Impairment of goodwill	307,590	0
Amortization of operating lease right of use assets	5,260	5,742
Accretion of construction finance liabilities	792	595
Share-based compensation	2,876	10,267
Change in fair value of derivative liabilities - warrants	(252)	(2,262)
Non-cash change in contingencies	(7,188)	10,384
Allowance for credit losses	350	1,088
Deferred income tax expense	(12,236)	(13,669)
Loss from disposal of discontinued operations	69,275
Changes in operating assets and liabilities:
Inventories	40,333	(55,736)
Accounts receivable	(664)	(4,090)
Prepaid expenses and other current assets	4,957	2,362
Other assets	1,704	(4,422)
Accounts payable and accrued liabilities	(4,338)	(2,930)
Income tax payable	(49,728)	(3,674)
Other current liabilities	(8,066)	(1,331)
Operating lease liabilities	(4,876)	(4,543)
Deferred revenue	(3,782)	(797)
Other long-term liabilities	10,396	671
Net cash provided by operating activities	(23,062)	(10,284)
Cash flow from investing activities
Purchases of property and equipment	(24,720)	(92,865)
Purchases of property and equipment related to construction finance liabilities		(13,247)
Capitalized interest	(795)	(2,676)
Acquisitions and divestments, net of cash	977	(26,177)
Purchases of internal use software	(4,383)	(4,887)
Cash paid for license	(3,971)
Proceeds from sale of long-lived assets	3,785	100
Proceeds from sale of held for sale assets	3,431	2,173
Proceeds received from notes receivable	358	1,187
Net cash used in investing activities	(25,318)	(136,392)
Cash flow from financing activities
Proceeds from debt financings, net of discounts		76,715
Proceeds from construction finance liabilities		7,047
Proceeds from equity exercises		19,346
Payments on notes payable	(4,828)	(2,486)
Payments on private placement notes		(1,874)
Payments on finance lease obligations	(3,895)	(3,205)
Payments on construction finance liabilities	(562)	(636)
Payments on debt issuance costs		(189)
Payments for taxes related to net share settlement of equity awards		(230)
Distributions	(50)	(50)
Net cash (used in) provided by financing activities	(9,335)	94,438
Net decrease in cash and cash equivalents	(57,715)	(52,238)
Cash, cash equivalents, and restricted cash, beginning of period	213,792	229,644
Cash and cash equivalents of discontinued operations, beginning of period	5,702	4,015
Less: cash and cash equivalents of discontinued operations, end of period	(1,835)	(14,881)
Cash, cash equivalents, and restricted cash, end of period	159,944	166,540
Supplemental disclosure of cash flow information
Interest	41,121	35,281
Income taxes, net of refunds	121,009	104,261
Other noncash investing and financing activities
ASC 842 lease additions - operating and finance leases	10,410	30,383
Purchases of property and equipment in accounts payable and accrued liabilities	2,682	10,084
Noncash partial extinguishment of construction finance liability	18,486
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Cash and Cash Equivalents, at Carrying Value, Beginning Balance	207,185	226,631
Restricted cash, beginning balance	6,607	3,013
Cash and Cash Equivalents, at Carrying Value, Ending Balance	152,369	$ 166,540
Restricted cash, ending balance	$ 7,575

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Net Cash Provided by (Used in) Discontinued Operations and Continuing Operations [Abstract]
Cash and cash equivalents, attributable to discontinued operations	$ 1.8	$ 5.7	$ 14.9	$ 4

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements of Trulieve Cannabis Corp., ("Trulieve" and, together with its subsidiaries and variable interest entities, the "Company," "our," or "us") has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and, therefore, do not include all financial information and footnotes required by GAAP for complete financial statements. In management's opinion, the condensed consolidated financial statements include all adjustments of a normal recurring nature necessary to fairly present the Company's financial position as of June 30, 2023, and the results of its operations and cash flows for the periods ended June 30, 2023 and 2022. The results of the Company's operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full 2023 fiscal year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for Trulieve Cannabis Corp. and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission ("SEC") on March 8, 2023 (the "2022 Form 10-K"). Discontinued Operations During the three months ended June 30, 2023, the Company determined to exit our operations in Massachusetts which represented a strategic shift in the business. The related assets and liabilities associated with the Company's discontinued operations are classified as discontinued operations on the condensed consolidated balance sheets and the results of our discontinued operations have been presented as discontinued operations within the condensed consolidated statements of operations for all periods presented. Unless specifically noted otherwise, footnote disclosures reflect the results of continuing operations only. The results of discontinued operations are presented in Note 16. Discontinued Operations . Reclassifications Certain reclassifications have been made to the condensed consolidated financial statements of prior periods and of the accompanying notes to conform to the current period presentation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The Company’s significant accounting policies are more fully described in Note 3. Summary of Significant Accounting Policies in the consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022. There have been no material changes to the Company’s significant accounting policies. Prepaid and other current assets During the three months ended June 30, 2023, escrow of $ 22.5 million was released related to the settlement of previous litigation which was previously recorded to prepaid and other current assets, of which $ 17.0 million was paid in cash and $ 5.5 million was relieved. Fair Value of Finan cial Instruments The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 – Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices in active markets, which are observable for the asset or liability, either directly or indirectly; and Level 3 – Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions. The fair values of financial instruments by class are as follows as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total (in thousands) Financial Assets: Money market funds (1) $ 95,545 $ — $ — $ 95,545 $ 340 $ — $ — $ 340 Financial Liabilities: Interest rate swap (2) $ — $ 1,544 $ — $ 1,544 $ — $ 2,536 $ — $ 2,536 Warrant liabilities (3) $ — $ — $ — $ — $ — $ 252 $ — $ 252 There have been no transfers between hierarchy levels during the periods ending June 30, 2023 or December 31, 2022. (1) Money market funds are included within cash and cash equivalents and restricted cash in the Company’s condensed consolidated balance sheets. As short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that approximate fair value. The Company recorded interest income of $ 1.1 million and $ 1.8 million during the three and six months ended June 30, 2023 in relation to money market funds. (2) The fair value of the interest rate swap liability is recorded in other long-term liabilities on the condensed consolidated balance sheets. In November 2022 the Company entered into an interest rate swap contract ("VNB Swap") for the purpose of hedging the variability of interest expense and interest payments on the Company's long-term variable debt. The VNB Swap is carried at fair value which is based on a valuation model that utilizes interest rate yield curves and credit spreads observable in active markets as the significant inputs to the model. The Company considers credit risk associated with its own standing as well as the credit standing of any counterparties involved in the valuation of its financial instruments. (3) The total fair value and carrying value of the Company's liability warrants is recorded to warrant liabilities on the condensed consolidated balance sheets . All remaining liability warrants expired during the three months ended June 30, 2023. Deferred Revenue During the three months ended March 31, 2023, the Company terminated the loyalty program associated with dispensaries acquired with the acquisition of Harvest Health & Recreation, Inc. ("Harvest") in October 2021. As a result of the termination of the loyalty program at certain dispensaries, the Company recorded a reduction in the accrual of $ 4.7 million in revenue, net of discounts in the condensed consolidated statements of operations. As of June 30, 2023 and December 31, 2022, the loyalty liability totaled $ 5.1 million and $ 8.9 million , respectively, and is included in deferred revenue on the condensed consolidated balance sheets. Included within deferred revenue as of June 30, 2023 and December 31, 2022 are customer credit balances of $ 0.7 million and $ 0.5 million , respectively. Impairment of Long-Lived Assets The Company reviews long-lived assets, including property and equipment, definite life intangible assets, and right-of-use assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. During the three months ended March 31, 2023, the Company determined that certain long-lived assets, including intangible assets, in Massachusetts were impaired due to the competitive environment in the Massachusetts cannabis industry. The Company utilized a cost approach for its impairment testing of property and equipment resulting in an impairment of $ 30.3 million, of which $ 27.6 million relates to discontinued operations and recorded to net loss from discontinued operations, net of tax benefit, and $ 2.7 million relates to continuing operations recorded in impairment and disposal of long-lived assets, net in the condensed consolidated statements of operations, respectively. During the three months ended June 30, 2023, the Company did not identify any events or changes in circumstances providing indication of impairment, other than the Company discontinuing its operations in Massachusetts in the normal course of business. Impairment of Goodwill The Company operates as one operating segment and reporting unit and therefore, evaluates goodwill for impairment as one singular reporting unit annually during the fourth quarter or more often when an event occurs, or circumstances indicate the carrying value may not be recoverable. The determination of the fair value of the reporting unit requires us to make significant estimates and assumptions. Due to the inherent uncertainty involved in making these estimates, actual future results could differ. Changes in assumptions regarding future results or other underlying assumptions could have a significant impact on the fair value of the reporting unit. The discounted cash flow model, or the income approach, reflects our estimates of future cash flows and other factors including estimates of future operating performance, including future revenue, long-term growth rates, gross margins, capital expenditures, discount rates and the probability of achieving the estimated cash flows, among others. In addition to the income approach, the Company also employs the market approach in its goodwill impairment testing. Under the market approach, the Company estimates the fair value based upon multiples of comparable public companies. Significant estimates in the market approach include identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, as well as assessing comparable market multiples in estimating the fair value of the reporting unit. During the three months ending March 31, 2023, the Company continued to experience a decline in its stock price resulting in the total market value of its common stock outstanding ("market capitalization") being less than the carrying value of the reporting unit. Management believes this decline in market value is due to a variety of factors, as further described below. In light of the circumstances and indicators of potential impairment described above, management performed an interim quantitative goodwill impairment test as of March 31, 2023. Management first considered whether any impairment was present for the Company’s long-lived assets, concluding that no such impairments were present after conducting an undiscounted cash flow recoverability test, except for in the Massachusetts market as detailed above. In comparing the estimated fair value of the reporting unit to its carrying value, the Company utilized a weighted average valuation using the discounted cash flow model and the market approach. The results of the Company’s interim test for impairment as of March 31, 2023 concluded that the estimated fair value of the reporting unit exceeded the carrying value, resulting in no impairment. During the three months ended June 30, 2023, the Company continued to experience a declined stock price resulting in the market capitalization being less than the carrying value of the reporting unit. The Company updated the March 31, 2023 valuation, as of June 30, 2023, with no impairment identified finding all inputs, including but not limited to future operating performance, gross margins, probability of achieving cash flows, and multiples of comparable public companies, either maintained consistency or trended positively for the three months ended June 30, 2023. Furthermore, the Company performed a sensitivity test on the income approach updating for the exit of the Massachusetts operations identifying the Massachusetts exit accretive to earnings as the Massachusetts assets were underperforming. However, the Company concluded the sustained stock price decline as a triggering event to perform an interim quantitative goodwill impairment test, as of June 30, 2023, specific to the stock price decline and resulting market capitalization of the Company. As the sole risk to the value of goodwill is the stock price, the Company concluded it most appropriate to transition to a market approach. The results of the Company’s interim test for impairment as of June 30, 2023, utilizing a market approach, indicated that the reporting unit's fair value fell below the carrying value. Based on the results of the goodwill impairment procedures, the Company recorded a $ 307.6 million goodwill impairment for the single reporting unit during the three months ended June 30, 2023. The Company finds the June 30, 2023 goodwill impairment is a result of the cannabis equity market including the reduced number of custodians to service cannabis equity holdings, negative investor sentiment due to lack of progress on federal reform, and more challenging macroeconomic conditions driving lower cannabis stock prices as of June 30, 2023. The Company finds this is not a negative indicator of historic or current operating results and not a negative indicator of future performance as the Company has taken steps to shed underperforming assets while focusing on cash conservation which is reflective in the results of operations as of June 30, 2023. Additionally, the resulting non-cash charge has no impact on the Company’s compliance with debt covenants, its cash flows, or available liquidity.

Accounts Receivable

Accounts Receivable	6 Months Ended
	Jun. 30, 2023
Receivables [Abstract]
Accounts Receivable	NOTE 3 . ACCOUNTS RECEIVABLE Accounts receivable consisted of the following as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 (in thousands) Trade receivables $ 9,846 $ 8,482 Less: allowance for credit losses ( 2,833 ) ( 1,975 ) Accounts receivable, net $ 7,013 $ 6,507

Notes Receivable

Notes Receivable	6 Months Ended
	Jun. 30, 2023
Receivables [Abstract]
Notes Receivable	NOTE 4 . NOTES RECEIVABLE Notes receivable consisted of the following as of June 30, 2023 and December 31, 2022: June 30, December 31, Stated Interest Rate Maturity Date (in thousands) Promissory note acquired in October 2021 (1) $ 7,847 $ 8,205 7.50 % 11/9/2025 Promissory note dated November 15, 2021 (2) 4,830 4,602 9.75 % 11/14/2024 Notes receivable 12,677 12,807 Less: discount on notes receivable ( 68 ) ( 87 ) Total notes receivable, net of discount 12,609 12,720 Less: current portion of notes receivable ( 754 ) ( 728 ) Notes receivable, net $ 11,855 $ 11,992 (1) Interest and principal payments are due to the Company monthly. (2) No payments are due to the Company until maturity. Interest is accrued monthly and added to the principal balance at each quarter end. The note is convertible to equity of the holder at the Company's option at any time prior to maturity. The note was issued with a nominal discount, resulting in an effective interest rate of 10.77 %. During the three and six months ended June 30, 2023, the Company recorded interest income related to notes receivable of $ 0.3 million and $ 0.6 million, respectively. During the three and six months ended June 30, 2022, the Company recorded interest income of $ 0.3 million and $ 0.7 million, respectively. Interest income is recorded in other income in the condensed consolidated statements of operations. Stated maturities of the notes receivable are as follows as of June 30, 2023: Year Expected principal payments (in thousands) Six months ending December 31, 2023 $ 370 2024 5,614 2025 6,693 2026 — 2027 — Thereafter — Total 12,677 Less: discount on notes receivable ( 68 ) Total $ 12,609

Inventories

Inventories	6 Months Ended
	Jun. 30, 2023
Inventory Disclosure [Abstract]
Inventories	NOTE 5. INVENTORIES Inventories are stated at the lower of cost or market. Costs associated with abnormal production volume are expensed as incurred. Inventories are comprised of the following as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 (in thousands) Raw material Cannabis plants $ 17,064 $ 21,523 Packaging and supplies 42,051 49,650 Total raw material 59,115 71,173 Work in process 134,167 158,448 Finished goods-unmedicated 5,915 7,323 Finished goods-medicated 53,588 39,561 Total inventories, net $ 252,785 $ 276,505

Property And Equipment

Property And Equipment	6 Months Ended
	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Property And Equipment	NOTE 6 . PROPERTY AND EQUIPMENT As of June 30, 2023 and December 31, 2022, property and equipment consisted of the following: June 30, 2023 December 31, 2022 (in thousands) Land $ 34,485 $ 38,485 Buildings and improvements 514,711 497,493 Furniture and equipment 288,831 277,164 Vehicles 838 839 Total 838,865 813,981 Less: accumulated depreciation ( 163,269 ) ( 125,866 ) Total property and equipment 675,596 688,115 Construction in progress 33,059 55,145 Total property and equipment, net $ 708,655 $ 743,260 The Company incurred the following expense related to property and equipment during the three and six months ended June 30, 2023: Three Months Ended June 30, Six Months Ended June 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Capitalized interest Interest expense $( 214 ) $( 1,160 ) $( 795 ) $( 2,640 ) Depreciation expense Cost of goods sold and Depreciation and amortization 19,334 18,587 38,331 32,685 Total $ 19,120 $ 17,427 $ 37,536 $ 30,045 Three Months Ended June 30, Six Months Ended June 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Loss on impairment Impairments and disposals of long-lived assets, net $ — $ — $ 2,712 $ 330 Loss on disposal Impairments and disposals of long-lived assets, net 3,927 5,076 3,667 8,067 Total $ 3,927 $ 5,076 $ 6,379 $ 8,397

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 7 . INTANGIBLE ASSETS The Company's definite-lived intangible assets consisted of the following as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Gross Carrying Amount Accumulated Amortization Net Book Value (in thousands) (in thousands) Licenses $ 1,046,544 $ 124,186 $ 922,358 $ 1,044,161 $ 89,367 $ 954,794 Trademarks 27,430 15,122 12,308 27,430 12,530 14,900 Internal use software 20,911 5,112 15,799 16,528 3,065 13,463 Tradenames 4,861 4,049 812 4,862 3,506 1,356 Customer relationships 3,535 3,352 183 3,536 3,252 284 Total $ 1,103,281 $ 151,821 $ 951,460 $ 1,096,517 $ 111,720 $ 984,797 Amortization expense was $ 20.2 million , $ 40.1 million , $ 20.5 million , and $ 41.1 million for the three and six months ended June 30, 2023 and 2022, respectively. During the three and six months ended June 30, 2023, the Company recorded a gain on sale of intangible assets of $ 3.0 million , which is recorded to impairment and disposal of long-lived assets, net within the condensed consolidated statements of operations. The following table outlines the estimated future amortization expense related to intangible assets as of June 30, 2023: Year Estimated (in thousands) Six Months Ending December 31, 2023 $ 40,592 2024 79,744 2025 76,677 2026 74,105 2027 71,604 Thereafter 608,738 $ 951,460 As of June 30, 2023, the weighted average amortization period remaining for intangible assets was 12.9 years.

Held for Sale

Held for Sale	6 Months Ended
	Jun. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Held for Sale	NOTE 16 . DISCONTINUED OPERATIONS During the three months ended June 30, 2023, the Company determined to discontinue its operations in Massachusetts. In July 2022, the Company discontinued its Nevada operations. There are immaterial activities related to Nevada which are expected to continue until the associated lease liabilities are settled. The assets and liabilities associated with discontinued operations consisted of the following as June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 (in thousands) Assets associated with discontinued operations Cash $ 1,835 $ 5,702 Accounts receivable, net 2,744 2,936 Inventories, net 3,230 21,310 Income tax receivable 2,718 2,267 Prepaids expenses and other current assets 947 1,486 Deferred tax asset — 766 Property and equipment, net — 53,687 Right of use assets - operating, net — 1,769 Right of use assets - finance, net — 5,736 Intangible assets, net — 27,849 Other assets 2,013 2,638 Total assets associated with discontinued operations $ 13,487 $ 126,146 Liabilities associated with discontinued operations Accounts payable and accrued liabilities $ 1,120 $ 1,617 Deferred revenue — 109 Operating lease liabilities - current portion 70 93 Finance lease liabilities - current portion 427 456 Construction finance liability - current portion 1,794 — Operating lease liabilities 14,686 16,428 Finance lease liabilities 2,829 5,890 Construction finance liability 25,237 45,217 Other long-term liabilities 156 154 Total liabilities associated with discontinued operations $ 46,319 $ 69,964 The following table summarizes the Company's income (loss) from discontinued operations for the three and six months ended June 30, 2023 and 2022. The gain and loss resulting from the forgiveness of intercompany payables has been eliminated in consolidation. Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Revenues, net of discounts $ 4,472 $ 6,444 $ 8,347 $ 14,231 Cost of goods sold 22,872 7,663 26,972 17,155 Gross margin ( 18,400 ) ( 1,219 ) ( 18,625 ) ( 2,924 ) Expenses: Operating expenses 1,994 2,984 4,382 6,049 Impairment and disposal of long-lived assets, net 41,639 — 69,275 — Total Expenses 43,633 2,984 73,657 6,049 Income (loss) from operations ( 62,033 ) ( 4,203 ) ( 92,282 ) ( 8,973 ) Other (expense) income: Interest expense ( 1,589 ) ( 1,534 ) ( 3,178 ) ( 3,058 ) Other income, net — 30 22 60 Total other expense, net ( 1,589 ) ( 1,504 ) ( 3,156 ) ( 2,998 ) Loss before provision for income taxes ( 63,622 ) ( 5,707 ) ( 95,438 ) ( 11,971 ) Income tax (provision) benefit ( 946 ) 473 ( 439 ) 1,299 Net loss from discontinued operations, net of tax (provision) benefit ( 64,568 ) ( 5,234 ) ( 95,877 ) ( 10,672 ) Less: Net loss attributable to non-controlling interest from discontinued operations ( 670 ) — ( 1,193 ) — Net loss from discontinued operations excluding non-controlling interest $ ( 63,898 ) $ ( 5,234 ) $ ( 94,684 ) $ ( 10,672 ) The condensed consolidated statements of cash flows include continuing operations and discontinued operations. The following table summarizes the depreciation of long-lived assets, amortization of long-lived assets, and capital expenditures of discontinued operations for the three and six months ended June 30, 2023 and 2022. Six Months Ended June 30, 2023 2022 Depreciation $ 2,917 $ 2,875 Amortization $ 535 $ 2,795 Purchases of property plant and equipment $ 67 $ 685 Loss on impairment of long-lived assets $ 69,275 $ — Other noncash investing and financing activities Noncash partial extinguishment of construction finance liability $ 18,486 $ — As a result of the Massachusetts exit, the Company performed a lease term reassessment for the Holyoke failed sale-leaseback financing arrangement due to lease renewals previously included in the lease term being excluded as of the Massachusetts exit. The Company concluded the failed sale-leaseback accounting conclusion is maintained. The Company recognized a gain on partial extinguishment of $ 18.5 million as a result of the lease term reassessment, which partially offset the loss on disposal of the related property and improvements of $ 45.8 million which is recorded to net loss from discontinued operations, net of tax (provision) benefit. The lease had a term of ten years and was extended by one year to an eleven year term, expiring in December 2030 . Future minimum lease payments for the construction finance liability as of June 30, 2023, are as follows: Year (in thousands) Six months ending December 31, 2023 $ 2,682 2024 5,455 2025 5,619 2026 5,788 2027 5,961 Thereafter 18,427 Total future payments 43,932 Less: Interest ( 16,901 ) Total present value of minimum payments 27,031 Construction finance liability - current portion ( 1,794 ) Construction finance liability $ 25,237
Held For Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Held for Sale	NOTE 8. HELD FOR SALE As of June 30, 2023, the Company had $ 17.2 million in assets held for sale, which are recorded in prepaids and other current assets on the condensed consolidated balance sheets, and primarily consist of property and equipment. As of December 31, 2022, the Company had $ 14.5 million in assets held for sale which primarily consisted of property and equipment. (in thousands) Held for sale assets as of December 31, 2022 $ 14,521 Assets moved to held for sale 10,411 Non-cash settlement ( 2,481 ) Impairments ( 1,994 ) Assets sold ( 3,268 ) Held for sale assets as of June 30, 2023 $ 17,189 Held for sale liabilities as of December 31, 2022 $ — Liabilities moved to held for sale ( 1,997 ) Liabilities settled associated with held for sale assets 1,997 Held for sale liabilities as of June 30, 2023 $ — During the three and six months ended June 30, 2023, the Company recorded a loss on the impairment and disposal of held for sale assets of $ 1.8 million and $ 2.6 million , respectively, and less than $ .1 million and $ 2.6 million during the three and six months ended June 30, 2022, respectively, which is recorded to impairment and disposal of long-lived assets, net within the condensed consolidated statements of operations .

Notes Payable

Notes Payable	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Notes Payable	NOTE 9 . NOTES PAYABLE As of June 30, 2023 and December 31, 2022, notes payable consisted of the following: June 30, 2023 December 31, 2022 Stated Interest Rate Effective Interest Rate Maturity Date Net Book Value of Collateral (in thousands) Promissory notes dated December 21, 2022 (1) $ 70,839 $ 71,500 7.53 % (4) 7.86 % 1/1/2028 $ 156,667 Promissory note dated December 22, 2022 (2) 18,687 18,900 7.30 % (4) 7.38 % 12/22/2032 $ 9,375 Promissory notes dated October 1, 2021 (3) 5,856 6,095 8.14 % (4) 8.29 % 10/1/2027 $ 11,555 Promissory note dated December 22, 2022 5,500 5,500 10.00 % (4) 10.00 % 12/22/2023 (5) Promissory notes acquired in October 2021 1,778 5,338 (6) (4) (6) (6) (6) Promissory note of consolidated variable-interest entity dated February 1, 2022 1,045 1,200 8.00 % (4) 8.00 % 12/31/2025 — Total notes payable 103,705 108,533 Less: debt discount ( 1,671 ) ( 1,833 ) Less: current portion of notes payable ( 9,076 ) ( 12,453 ) Notes payable, net (7) $ 92,958 $ 94,247 (1) In connection with the closing of these four promissory notes, the Company entered into an interest rate swap to fix the interest rate at 7.53 % for the term of the notes. See Note 23 in the 2022 Form 10-K fo r further details. These promissory notes contain customary restrictive covenants pertaining to our management and operations, including, among other things, limitations on the amount of debt that may be incurred and the ability to pledge assets, among other things, as well as financial covenant requirements, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements, fixed charge ratio coverage, and liquidity covenant test. The covenants commence on June 30, 2023 and are measured semi-annually, except for certain covenants which were measured starting as of December 31, 2022. In May 2023, the Company amended the terms of the agreement in respect to the covenant requirements, excluding balloon payments from certain covenant calculations. (2) Promissory note bears interest at 7.30 % per annum until December 21, 2027. Thereafter, interest will accrue at a rate equal to the five-year treasury rate in effect as of December 12, 2027 plus 3.50 %. The promissory note contains customary restrictive covenants pertaining to our operations, including, among other things, limitations on the amount of debt and subsidiary debt that may be incurred and the ability to pledge assets, as well as financial covenant requirements, among other things, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements, covenant to liquidity and debt principal test, and a global debt service coverage ratio. The covenants commence on December 31, 2022 and December 31, 2023 and are measured annually. (3) On November 15, 2022 , the Company closed on the refinancing of our promissory notes dated October 1, 2021 to extend the maturity date by five years and fix the interest rate at 8.14 %. During the three months ended March 31, 2023, the Company determined to reposition the collateralized assets to held for sale as part of its continued efforts to optimize our assets and resources in the markets in which it serves. The Company expects to sell the assets, which primarily consist of property and equipment, within the near-term. (4) Interest payments are due monthly . (5) Promissory note is secured by the acquired membership interest in Formula 420 Cannabis LLC. See Note 4 in the 2022 Form 10-K fo r further details . (6) Seven promissory notes were acquired during the year ending December 31, 2021. Interest rates range from 0.00 % to 5.50 % , with a weighted average interest rate of 5.38 % as of June 30, 2023. Maturity dates range from July 2023 to April 2026 . Of the seven acquired promissory notes, three remain outstanding as of June 30, 2023. The three notes are secured by various assets that approximate the value of the underlying notes of $ 1.8 million as of June 30, 2023 . (7) In addition to the notes payable listed in the above table, the Company entered into a letter of credit in October 2022 for up to $ 1.5 million, for which there have been no draws as of June 30, 2023 . The letter of credit is payable on demand, has an interest rate of 6.25 %, and must be drawn on by October 2023 or will expire. During the three and six months ended June 30, 2023, the Company incurred interest expense related to these notes payable of $ 2.1 million and $ 4.2 million , respectively, and during the three and six months ended June 30, 2022, the Company incurred interest expense of $ 0.2 million and $ 0.3 million , respectively, which is included within interest expense in the condensed consolidated statements of operations. This includes accretion expense of $ 0.1 million and $ 0.2 million , respectively, for the three and six months ended June 30, 2023 and $ 0.1 million and $ 0.1 million , respectively, for the three and six months ended June 30, 2022. The Company's notes payable described above are subordinated to the private placement notes. See Note 10. Private Placement Notes for further details. As of June 30, 2023, stated maturities of notes payable are as follows: (in thousands) Six months ended December 31, 2023 $ 7,788 2024 3,232 2025 3,888 2026 3,044 2027 69,352 Thereafter 16,401 Total $ 103,705

Private Placement Notes

Private Placement Notes	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Private Placement Notes	NOTE 10 . PRIVATE PLACEMENT NOTES June and November Notes In 2019, the Company completed two private placement arrangements (the “June Notes” and the “November Notes”), each comprised of 5-year senior secured promissory notes with a face value of $ 70.0 million and $ 60.0 million, respectively. The purchasers of the June Notes received warrants to purchase 1,470,000 Subordinate Voting Shares at a price of $ 13.47 ("June Warrants") and the purchasers of the November Notes received warrants to purchase 1,560,000 Subordinate Voting Shares at a price of $ 980 per Unit, with each unit consisting of one Note issued in Denominations of $ 1,000 and 26 warrants ("November Warrants"), which can be exercised for approximately three years after closing (collectively the "Public Warrants"). The remaining outstanding Public Warrants expired in June 2022. 2026 Notes On October 6, 2021, the Company closed its private placement of 8 % Senior Secured Notes (the "2026 Notes - Tranche One") for aggregate gross proceeds of $ 350.0 million and net proceeds of $ 342.6 million. The Company used a portion of the net proceeds to repay certain outstanding acquired indebtedness and used the remaining net proceeds for capital expenditures and other general corporate purposes. On January 28, 2022, the Company closed on a second tranche private placement of 8 % Senior Secured Notes (the "2026 Notes - Tranche Two") for aggregate gross proceeds of $ 76.9 million and net proceeds of $ 75.6 million. The Company used the net proceeds for capital expenditures and other general corporate purposes. The notes may be redeemed in whole or in part, at the Company's option, at any time, on or after October 6, 2023, at the applicable redemption price. These notes are collectively referred to as the "2026 Notes". As of June 30, 2023 and December 31, 2022, private placement notes payable consisted of the following: June 30, 2023 December 31, 2022 Stated Interest Rate Effective Interest Rate Maturity Date (in thousands) 2026 Notes - Tranche One $ 350,000 $ 350,000 8.00 % 8.52 % 10/6/2026 2026 Notes - Tranche Two 75,000 75,000 8.00 % 8.43 % 10/6/2026 June Notes 70,000 70,000 9.75 % 13.32 % 6/11/2024 November Notes 60,000 60,000 9.75 % 13.43 % 6/11/2024 Total private placement notes 555,000 555,000 Less: Unamortized debt discount and issuance costs ( 10,534 ) ( 13,336 ) Less: current portion of private placement notes, net ( 125,861 ) — Private placement notes, net $ 418,605 $ 541,664 The private placement notes contain customary restrictive covenants pertaining to our management and operations, including, among other things, limitations on the amount of debt that may be incurred and the ability to pledge assets, as well as financial covenant requirements, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements and a fixed charge ratio coverage, measured from time to time when certain conditions are met. During the three and six months ended June 30, 2023, the Company incurred interest expense related to private placement notes of $ 13.0 million and $ 25.9 million , respectively, and during the three and six months ended June 30, 2022, the Company incurred interest expense of $ 13.5 million and $ 25.8 million , respectively, which is included within interest expense in the condensed consolidated statements of operations related to the private placement notes. This includes accretion expense on the private placement notes of $ 1.4 million and $ 2.8 million , respectively, for the three and six months ended June 30, 2023 and $ 1.3 million and $ 2.5 million , respectively, for the three and six months ended June 30, 2022. Stated maturities of the principal portion of private placement notes outstanding as of June 30, 2023, are as follows: Year (in thousands) Six months ending December 31, 2023 $ — 2024 130,000 2025 — 2026 425,000 2027 — Thereafter — Total private placement notes $ 555,000

Leases

Leases	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Leases	NOTE 11. LEASES The Company leases real estate used for dispensaries, cultivation and production facilities, and corporate offices. Lease terms for real estate generally range from five to ten years . Most leases include options to renew for varying terms at the Company’s sole discretion. Other leased assets include passenger vehicles, trucks, and equipment. Lease terms for these assets generally range from three to five years . Lease right-of-use assets and liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for taxes, insurance and maintenance which are considered non-lease components. The Company accounts for real estate leases and the related fixed non-lease components together as a single component. The Company recorded a loss on disposal of right of use assets of less than $ 0.1 million and $ 10.5 million for the three and six months ended June 30, 2022, which is the result of repositioning of assets in the southeast, which is recorded to impairment and disposal of long-lived assets, net within the condensed consolidated statements of operations. The following table provides the components of lease cost recognized within the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended Six Months Ended June 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Operating lease cost Cost of goods sold, sales and marketing, general and administrative $ 5,289 $ 5,515 $ 10,200 $ 10,979 Finance lease cost: Amortization of lease assets Cost of goods sold and Depreciation and amortization 2,578 2,581 5,353 4,986 Interest on lease liabilities Interest expense 1,613 1,568 3,221 3,056 Finance lease cost 4,191 4,149 8,574 8,042 Variable lease cost Cost of goods sold, sales and marketing, general and administrative 2,450 1,878 4,716 3,792 Short term lease expense Cost of goods sold, sales and marketing, general and administrative 166 156 369 255 Total lease cost $ 12,096 $ 11,698 $ 23,859 $ 23,068 Other information related to operating and finance lease s is as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 5,005 $ 5,271 $ 10,067 $ 10,166 Operating cash flows from finance leases $ 1,612 $ 1,559 $ 3,267 $ 3,047 Financing cash flows from finance leases $ 1,748 $ 1,721 $ 3,671 $ 3,075 ASC 842 lease additions and modifications: Operating leases $ 6,406 $ 2,404 $ 11,008 $ 11,970 Finance leases $ 173 $ 12,112 $ 116 $ 18,413 June 30, 2023 December 31, 2022 Weighted average discount rate: Operating leases 10.00 % 9.29 % Finance leases 9.00 % 8.66 % Weighted average remaining lease term (in years): Operating leases 9.1 8.3 Finance leases 7.7 7.8 Future minimum lease payments under the Company's non-cancellable leases as of June 30, 2023 are as follows: Operating Leases Finance Leases (in thousands) Six months ending December 31, 2023 $ 9,719 $ 6,831 2024 20,420 13,680 2025 20,359 13,470 2026 19,708 12,605 2027 19,103 11,703 Thereafter 75,826 43,358 Total undiscounted lease liabilities 165,135 101,647 Less: Interest ( 54,736 ) ( 29,436 ) Total present value of minimum lease payments 110,399 72,211 Lease liabilities- current portion ( 9,668 ) ( 7,595 ) Lease liabilities $ 100,731 $ 64,616 Lease Guarantees In accordance with ASC 460, Guarantees, the Company has determined that it meets the guarantor requirements under certain contractual agreements. During the three months ending June 30, 2023, the Company determined it was no longer the primary beneficiary of one its variable interest entities. The Company guarantees two cannabis dispensary leases of the variable interest entity. Under both leases, nonperformance by the tenant results in the Company becoming obligated to fulfill the lease conditions. The leases have a term of approximately 8 and 9 years as of June 30, 2023, with the resulting maximum exposure estimated to be $ 5.8 million which includes $ 2.5 million and $ 3.3 million of undiscounted future minimum lease payments plus potential additional payments to satisfy maintenance, taxes, and insurance requirements under the remaining terms the Company is guarantor, respectively.

Construction Finance Liabilitie

Construction Finance Liabilities	6 Months Ended
	Jun. 30, 2023
Construction Finance Liability [Abstract]
Construction Finance Liabilities	NOTE 12. CONSTRUCTION FINANCE LIABILITIES When the Company enters into sale-leaseback transactions, it assesses whether a contract exists and whether there is a performance obligation to transfer control of the asset when determining whether the transfer of an asset shall be accounted for as a sale of the asset. If control is not transferred, based on the nature of the transaction, and therefore does not meet the requirements for a sale under the failed-sale-leaseback accounting model, the Company is deemed to own this real estate and reflects these properties on its consolidated balance sheets in property and equipment, net and depreciates them over the assets' useful lives. The liabilities associated with these leases are recorded to construction finance liabilities - current portion and construction finance liabilities on the condensed consolidated balance sheets. During the three and six months ended June 30, 2023, the Company recorded interest expense of $ 4.1 million and $ 8.2 million , respectively, and during the three and six months ended June 30, 2022, the Company recorded interest expense of $ 3.9 million and $ 7.7 million , respectively, related to construction finance liabilities, which is included in interest expense within the condensed consolidated statements of operations. Ben Bostic In October 2019, the Company sold property in Florida in exchange for cash of $ 17.0 million. Concurrent with the closing of the purchase, the buyer entered into a lease agreement with the Company, for continued operation as a licensed medical cannabis cultivation facility. Control was never transferred to the buyer-lessor because the transaction was determined to be a finance lease and did not meet the requirements of a sale. The transaction was treated as a failed sale-leaseback financing arrangement. As of June 30, 2023, and December 31, 2022, the total construction finance liability associated with this transaction is $ 17.8 million and $ 17.7 million , respectively. McKeesport In October 2019, the Company acquired a failed sales-leaseback transaction of a cannabis cultivation facility in Pennsylvania. The initial term of the lease is 15 years, with two five-year options to renew. As of June 30, 2023, and December 31, 2022, the total construction finance liability associated with this transaction is $ 42.1 million and $ 41.8 million , respectively. Alachua In October 2021, the Company acquired a failed sales-leaseback transaction of a cannabis cultivation and processing facility in Florida. The lease originated in January 2021 and has an initial term of 20 years , with two five-year options to renew. In the third quarter of 2022, the Company ceased using this facility and as a result recorded a loss on disposal of the related property and equipment of $ 42.4 million. As of June 30, 2023, and December 31, 2022, the total construction finance liability associated with this transaction is $ 59.2 million and $ 59.2 million , respectively. Hancock In October 2021, the Company acquired a failed sales-leaseback transaction of a cannabis cultivation and processing facility in Maryland. The lease originated in August 2021 and has an initial term of ten years with two options to extend the term, the first providing a ten-year renewal option and the second providing a five-year renewal option. The landlord has agreed to provide a tenant improvement allowance of $ 12.9 million as an additional component of base rent. As of June 30, 2023, and December 31, 2022, $ 12.3 million and $ 12.3 million of the tenant improvement allowance has been provided, respectively. As of June 30, 2023, and December 31, 2022, the total construction finance liability associated with this transaction is $ 19.1 million and $ 19.7 million , respectively. Future minimum lease payments for the construction finance liabilities as of June 30, 2023, are as follows: Year (in thousands) Six months ending December 31, 2023 $ 8,325 2024 17,043 2025 17,521 2026 18,013 2027 18,519 Thereafter 302,424 Total future payments 381,845 Less: Interest ( 243,582 ) Total present value of minimum payments 138,263 Construction finance liabilities - current portion ( 1,324 ) Construction finance liabilities $ 136,939

Equity

Equity	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Equity	NOTE 13. EQUITY Warrants Liability Warrants In October 2021 the Company acquired 1,679 warrants in connection with the acquisition of Harvest Health and Recreation, Inc. ("Harvest Liability Warrants"). Each acquired warrant is exercisable into one Multiple Voting Share. Changes in fair value are recognized as a component of other (expense) income within t he condensed consolidated statements of operations as change in fair value of derivative liabilities - warrants. Number Weighted average exercise price Weighted average Outstanding and exercisable as of January 1, 2023 1,679 $ 1,125 0.31 Granted — — — Exercised — — — Expired ( 1,679 ) 1,125 — Outstanding and exercisable as of June 30, 2023 — $ — — Share Based Compensation Options The Company recorded share-based compensation for stock options as follows: Three Months Ended June 30, Six Months Ended June 30, Statement of operations location 2023 2022 2023 2022 (in thousands) Cost of goods sold $ 19 $ ( 56 ) $ 35 $ 70 General and administrative ( 275 ) 2,195 469 3,936 Sales and marketing 13 439 33 729 Total share-based compensation expense $ ( 243 ) $ 2,578 $ 537 $ 4,735 The number and weighted-average exercise prices and remaining contractual life of options as of June 30, 2023 were as follows: Number of options Weighted average exercise price Weighted average remaining contractual life (Yrs.) Aggregate intrinsic value Outstanding, January 1, 2023 3,177,815 $ 25.96 5.41 $ — Granted — — Exercised — — Forfeited ( 334,864 ) 30.29 Outstanding, June 30, 2023 2,842,951 $ 25.45 4.66 $ — Exercisable, June 30, 2023 2,222,348 $ 25.67 3.59 $ — As of June 30, 2023, there was approximately $ 2.0 million of unrecognized compensation cost related to unvested stock option arrangements which is expected to be recognized over a weighted average service period of 0.61 years. Restricted Stock Units The following is a summary of RSU activity for the six months ended June 30, 2023 Number of Weighted average Unvested balance as of January 1, 2023 720,707 $ 22.36 Granted — Vested — Forfeited ( 102,064 ) 23.03 Unvested balance as of June 30, 2023 618,643 $ 22.21 The Company recorded share-based compensation for RSUs as follows: Three Months Ended June 30, Six Months Ended June 30, Statement of operations location 2023 2022 2023 2022 (in thousands) Cost of goods sold $ 41 $ 258 $ 260 $ 458 General and administrative 601 2,567 1,920 4,462 Sales and marketing 76 300 159 612 Total share-based compensation expense $ 718 $ 3,125 $ 2,339 $ 5,532 As of June 30, 2023, there was approximately $ 4.8 million of total unrecognized compensation cost related to unvested restricted stock units, which is expected to be recognized over a weighted-average service period of 0.66 years.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Earnings Per Share	NOTE 14. EARNINGS PER SHARE The following is a reconciliation for the calculation of basic and diluted earnings per share: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Numerator (in thousands, except share and per share amounts) Continuing operations Net loss from continuing operations $ ( 342,304 ) $ ( 18,787 ) $ ( 376,626 ) $ ( 45,831 ) Less: Net loss attributable to non-controlling interest ( 2,353 ) ( 1,530 ) ( 3,337 ) ( 2,037 ) Net loss from continuing operations available to common shareholders of Trulieve Cannabis Corp. $ ( 339,951 ) $ ( 17,257 ) $ ( 373,289 ) $ ( 43,794 ) Discontinued operations Net loss from discontinued operations $ ( 64,568 ) $ ( 5,234 ) $ ( 95,877 ) $ ( 10,672 ) Less: Net loss attributable to non-controlling interest ( 670 ) — ( 1,193 ) — Net loss from discontinued operations excluding non-controlling interest $ ( 63,898 ) $ ( 5,234 ) $ ( 94,684 ) $ ( 10,672 ) Denominator Weighted average number of common shares outstanding - Basic and diluted 189,054,359 187,174,176 188,976,834 187,124,886 Loss per Share - Continuing operations Basic and diluted loss per share $ ( 1.80 ) $ ( 0.09 ) $ ( 1.98 ) $ ( 0.23 ) Loss per Share - Discontinued operations Basic and diluted loss per share $ ( 0.34 ) $ ( 0.03 ) $ ( 0.50 ) $ ( 0.06 ) Shares which have been excluded from diluted per share amounts because their effect would have been anti-dilutive are as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Stock options 2,842,951 3,465,639 2,985,093 3,547,090 Restricted share units 618,643 1,035,762 655,474 1,057,043 Warrants 9,496 767,500 93,444 2,201,764 As of June 30, 2023, there are approximately 186.0 million issued and outstanding shares which excludes approximately 2.9 million fully vested RSUs which are not contractually issuable until 2024.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 15 . INCOME TAXES The following table summarizes the Company’s income tax expense and effective tax rate for the three and six months ended June 30, 2023 and 2022. Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) (Loss) Income before provision for income taxes $ ( 308,277 ) $ 26,455 $ ( 307,142 ) $ 42,553 Provision for income taxes $ 34,027 $ 45,242 $ 69,484 $ 88,384 Effective tax rate ( 11 %) 171 % ( 23 %) 208 % The Company has computed its provision for income taxes based on the actual effective tax rate for the quarter as the Company believes this is the best estimate for the annual effective tax rate. The Company is subject to income taxes in the United States and Canada. Significant judgment is required in evaluating the Company’s uncertain tax positions and determining the provision for income taxes. The Company’s gross unrecognized tax benefits were approximately $ 49.5 million and $ 41.8 million as of June 30, 2023 and December 31, 2022 , respectively, which is recorded in deferred tax liabilities and other long-term liabilities in the condensed consolidated balance sheets. The increase of $ 7.7 million in uncertain tax positions i s due to a tax position taken relating to our inventory costs for tax purposes in our Florida dispensaries.

Discontinued Operations

Discontinued Operations	6 Months Ended
	Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	NOTE 16 . DISCONTINUED OPERATIONS During the three months ended June 30, 2023, the Company determined to discontinue its operations in Massachusetts. In July 2022, the Company discontinued its Nevada operations. There are immaterial activities related to Nevada which are expected to continue until the associated lease liabilities are settled. The assets and liabilities associated with discontinued operations consisted of the following as June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 (in thousands) Assets associated with discontinued operations Cash $ 1,835 $ 5,702 Accounts receivable, net 2,744 2,936 Inventories, net 3,230 21,310 Income tax receivable 2,718 2,267 Prepaids expenses and other current assets 947 1,486 Deferred tax asset — 766 Property and equipment, net — 53,687 Right of use assets - operating, net — 1,769 Right of use assets - finance, net — 5,736 Intangible assets, net — 27,849 Other assets 2,013 2,638 Total assets associated with discontinued operations $ 13,487 $ 126,146 Liabilities associated with discontinued operations Accounts payable and accrued liabilities $ 1,120 $ 1,617 Deferred revenue — 109 Operating lease liabilities - current portion 70 93 Finance lease liabilities - current portion 427 456 Construction finance liability - current portion 1,794 — Operating lease liabilities 14,686 16,428 Finance lease liabilities 2,829 5,890 Construction finance liability 25,237 45,217 Other long-term liabilities 156 154 Total liabilities associated with discontinued operations $ 46,319 $ 69,964 The following table summarizes the Company's income (loss) from discontinued operations for the three and six months ended June 30, 2023 and 2022. The gain and loss resulting from the forgiveness of intercompany payables has been eliminated in consolidation. Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Revenues, net of discounts $ 4,472 $ 6,444 $ 8,347 $ 14,231 Cost of goods sold 22,872 7,663 26,972 17,155 Gross margin ( 18,400 ) ( 1,219 ) ( 18,625 ) ( 2,924 ) Expenses: Operating expenses 1,994 2,984 4,382 6,049 Impairment and disposal of long-lived assets, net 41,639 — 69,275 — Total Expenses 43,633 2,984 73,657 6,049 Income (loss) from operations ( 62,033 ) ( 4,203 ) ( 92,282 ) ( 8,973 ) Other (expense) income: Interest expense ( 1,589 ) ( 1,534 ) ( 3,178 ) ( 3,058 ) Other income, net — 30 22 60 Total other expense, net ( 1,589 ) ( 1,504 ) ( 3,156 ) ( 2,998 ) Loss before provision for income taxes ( 63,622 ) ( 5,707 ) ( 95,438 ) ( 11,971 ) Income tax (provision) benefit ( 946 ) 473 ( 439 ) 1,299 Net loss from discontinued operations, net of tax (provision) benefit ( 64,568 ) ( 5,234 ) ( 95,877 ) ( 10,672 ) Less: Net loss attributable to non-controlling interest from discontinued operations ( 670 ) — ( 1,193 ) — Net loss from discontinued operations excluding non-controlling interest $ ( 63,898 ) $ ( 5,234 ) $ ( 94,684 ) $ ( 10,672 ) The condensed consolidated statements of cash flows include continuing operations and discontinued operations. The following table summarizes the depreciation of long-lived assets, amortization of long-lived assets, and capital expenditures of discontinued operations for the three and six months ended June 30, 2023 and 2022. Six Months Ended June 30, 2023 2022 Depreciation $ 2,917 $ 2,875 Amortization $ 535 $ 2,795 Purchases of property plant and equipment $ 67 $ 685 Loss on impairment of long-lived assets $ 69,275 $ — Other noncash investing and financing activities Noncash partial extinguishment of construction finance liability $ 18,486 $ — As a result of the Massachusetts exit, the Company performed a lease term reassessment for the Holyoke failed sale-leaseback financing arrangement due to lease renewals previously included in the lease term being excluded as of the Massachusetts exit. The Company concluded the failed sale-leaseback accounting conclusion is maintained. The Company recognized a gain on partial extinguishment of $ 18.5 million as a result of the lease term reassessment, which partially offset the loss on disposal of the related property and improvements of $ 45.8 million which is recorded to net loss from discontinued operations, net of tax (provision) benefit. The lease had a term of ten years and was extended by one year to an eleven year term, expiring in December 2030 . Future minimum lease payments for the construction finance liability as of June 30, 2023, are as follows: Year (in thousands) Six months ending December 31, 2023 $ 2,682 2024 5,455 2025 5,619 2026 5,788 2027 5,961 Thereafter 18,427 Total future payments 43,932 Less: Interest ( 16,901 ) Total present value of minimum payments 27,031 Construction finance liability - current portion ( 1,794 ) Construction finance liability $ 25,237

Variable Interest Entities

Variable Interest Entities	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	NOTE 17 . V ariable Interest Entities The Company has entered into certain agreements with various entities related to the purchase and operation of cannabis dispensary, cultivation, and production licenses, in several states in which it determined to be variable interest entities. The Company's VIEs are not material to the consolidated financial position or operations as of June 30, 2023 and December 31, 2022 or for the three and six months ended June 30, 2023 and 2022. The Company determined certain of these entities to be variable interest entities in which it is the primary beneficiary. The Company holds ownership interests in these entities ranging from 46 % to 95 % either directly or through a proxy as of June 30, 2023. The Company consolidates these entities due to the other holder’s equity investment being insufficient to finance its activities without additional subordinated financial support and the Company meeting the power and economics criteria. In particular, the Company controls the management decisions and activities most significant to these VIEs, has provided a significant portion of the subordinated financial support to date, and/or holds membership interests exposing the Company to the risk of reward and/or loss. The Company allocates income and cash flows of the VIEs based on the outstanding ownership percentage in accordance with the underlying agreements, as amended. The Company has consolidated all identified variable interest entities for which the Company is the primary beneficiary in the accompanying condensed consolidated financial statements. During the three months ended March 31, 2023, the Company paid $ 0.4 million in cash and $ 1.7 million in subordinate voting shares earned but not yet issued, based on the completion of certain milestones required as part of the acquisition of one of the Company's consolidated variable interest entities. The Company previously paid $ 0.8 million in cash for certain milestones. As part of the Company's decision to exit the Massachusetts market during the three months ended June 30, 2023, it ceased its relationship with this variable interest entity. This terminated the payment of the $ 1.7 million subordinate voting shares earned but not yet issued. Based on the changes in circumstances, the Company reevaluated the variable interest entity, concluding it was no longer the primary beneficiary and as such, deconsolidated the entity during the three months ended June 30, 2023. The Company recorded a loss of $ 10.0 million related to the termination of the acquisition and deconsolidation of the variable interest entity which is included in the loss from discontinued operations in the condensed consolidated statements of operations for the three and six months ended June 30, 2023. During the three months ended June 30, 2023, the Company sold and divested of certain variable interest entities. The Company received cash proceeds of $ 1.8 million related to the sale and recorded a loss on divestment of $ 0.8 million which is included in impairments and disposals of long-lived assets, net in the condensed consolidated statements of operations. The Company no longer consolidates these VIEs since it is no longer considered the primary beneficiary. The following table presents the summarized assets and liabilities of the Company’s VIEs in which the Company does not hold a majority interest as of June 30, 2023 and December 31, 2022. The assets and liabilities in the table below include third-party assets and liabilities of our VIEs only and exclude intercompany balances that eliminate in consolidation as included on our condensed consolidated balance sheets. June 30, 2023 December 31, 2022 (in thousands) Current assets: Cash $ 6,703 $ 7,349 Accounts receivable, net 1,208 597 Inventories, net 8,359 7,590 Prepaids and other current assets 514 46 Total current assets 16,784 15,582 Property and equipment, net 27,923 25,994 Right of use asset - operating, net 2,817 — Right of use asset - finance, net 275 224 Intangible assets, net 17,830 17,947 Other assets 147 344 Total assets $ 65,776 $ 60,091 Current liabilities: Accounts payable and accrued liabilities $ 2,188 $ 3,713 Income tax payable 2,538 1,615 Deferred revenue 1 6 Finance lease liability - current portion 55 41 Total current liabilities 4,782 5,375 Notes payable 1,045 1,200 Operating lease liability 2,892 — Finance lease liability 229 185 Deferred tax liabilities 3,663 4,101 Other long-term liabilities 796 625 Total liabilities $ 13,407 $ 11,486

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
Related Parties	NOTE 18 . RELATED PARTIES The Company leases a cultivation facility and corporate office facility from an entity that is directly or indirectly owned by Kim Rivers, the Company's Chief Executive Officer and Chair of the board of directors, George Hackney, a former member of the Company's board of directors, and Richard May, a member of the Company's board of directors. As of June 30, 2023, and December 31, 2022, under ASC 842, the Company had the following related party operating leases on the condensed consolidated balance sheets: As of June 30, 2023 As of December 31, 2022 (in thousands) Right-of-use assets, net $ 755 $ 820 Lease liabilities: Lease liabilities - current portion $ 121 $ 113 Lease liabilities 679 751 Total related parties lease liabilities $ 800 $ 864 Lease expense recognized on related party operating leases was less than $ 0.1 million and $ 0.1 million for the three and six months ended June 30, 2023, respectively. Lease expense was less than $ 0.1 million and $ 0.1 million for the three and six months ended June 30, 2022 , respectively.

Revenue Disaggregation

Revenue Disaggregation	6 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue Disaggregation	NOTE 19. REVENUE DISAGGREGATION Net revenues are comprised of the following for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Retail $ 271,888 $ 297,603 $ 546,733 $ 587,645 Wholesale, licensing, and other 9,907 16,236 20,276 36,755 Revenue, net of discounts $ 281,795 $ 313,839 $ 567,009 $ 624,400

Commitments And Contingencies

Commitments And Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	NOTE 20 . COMMITMENTS AND CONTINGENCIES Operating Licenses Although the possession, cultivation, and distribution of cannabis is permitted in the states in which the Company operates, cannabis is a Schedule-I controlled substance and its use remains a violation of federal law. Since federal law criminalizing the use of cannabis preempts state laws that legalize its use, strict enforcement of federal law regarding cannabis would likely result in the Company’s inability to proceed with our business plans. In addition, the Company’s assets, including real property, inventory, cash and cash equivalents, equipment, and other goods, could be subject to asset forfeiture because cannabis is still federally illegal. Claims and Litigation In the ordinary course of business, the Company may be a party to litigation, investigations, inquiries, employment-related matters, disputes and other potential claims. As of June 30, 2023, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s condensed consolidated statements of operations. The Company does not believe it is probable that the outcome of any existing litigation, investigations, disputes or other potential claims will materially affect the Company or these financial statements in excess of amounts accrued. In connection with the acquisition of a cultivation operation from CP4 Group, LLC, in Phoenix, Arizona ("Watkins Cultivation Operation" or "Watkins"), in the prior period, the Company received a demand letter on October 12, 2022, related to the four potential earnouts. The earnouts were based on the completion of certain milestones related to construction and operations and contingent on the continued employment of key employee shareholders. The Company entered into a settlement agreement in April 2023 closing this matter. Contingencies The Company records contingent liabilities with respect to litigation on various claims in which it believes a loss is probable and can be estimated. As of June 30, 2023 and December 31, 2022, $ 1.6 million and $ 31.7 million was included in contingent liabilities on the condensed consolidated balance sheets related to litigation matters, respectively. During the three and six months ended June 30, 2023 the Company settled various claims resulting in a decrease to the accrual. As of June 30, 2023 and December 31, 2022, $ 0.8 million and $ 3.0 million , respectively, was included in contingent liabilities on the condensed consolidated balance sheets for estimates related to various sales tax matters. Regulatory Compliance The Company’s compliance with state and other rules and regulations may be reviewed by state and federal agencies. If the Company fails to comply with these regulations, the Company could be subject to loss of licenses, substantial fines or penalties, and other sanctions.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	NOTE 21 . SUBSEQUENT EVENTS In July 2023, the Company granted, under the Company’s 2021 Omnibus Incentive Plan, 1,754,817 stock options and 3,017,294 restricted share units to certain employees and directors. The shares vest over varying terms over a three-year period. The Company has not yet completed the fair value measurement for these awards as of the date of this filing.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Prepaid and Other Current Assets	Prepaid and other current assets During the three months ended June 30, 2023, escrow of $ 22.5 million was released related to the settlement of previous litigation which was previously recorded to prepaid and other current assets, of which $ 17.0 million was paid in cash and $ 5.5 million was relieved.
Principles of Consolidation	The accompanying unaudited condensed consolidated financial statements of Trulieve Cannabis Corp., ("Trulieve" and, together with its subsidiaries and variable interest entities, the "Company," "our," or "us") has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and, therefore, do not include all financial information and footnotes required by GAAP for complete financial statements. In management's opinion, the condensed consolidated financial statements include all adjustments of a normal recurring nature necessary to fairly present the Company's financial position as of June 30, 2023, and the results of its operations and cash flows for the periods ended June 30, 2023 and 2022. The results of the Company's operations for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the full 2023 fiscal year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for Trulieve Cannabis Corp. and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission ("SEC") on March 8, 2023 (the "2022 Form 10-K").
Discontinued operations	Discontinued Operations During the three months ended June 30, 2023, the Company determined to exit our operations in Massachusetts which represented a strategic shift in the business. The related assets and liabilities associated with the Company's discontinued operations are classified as discontinued operations on the condensed consolidated balance sheets and the results of our discontinued operations have been presented as discontinued operations within the condensed consolidated statements of operations for all periods presented. Unless specifically noted otherwise, footnote disclosures reflect the results of continuing operations only. The results of discontinued operations are presented in Note 16. Discontinued Operations .
Reclassifications	Reclassifications Certain reclassifications have been made to the condensed consolidated financial statements of prior periods and of the accompanying notes to conform to the current period presentation.
Fair Value of Financial Instruments	Fair Value of Finan cial Instruments The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 – Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities; Level 2 – Inputs other than quoted prices in active markets, which are observable for the asset or liability, either directly or indirectly; and Level 3 – Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions. The fair values of financial instruments by class are as follows as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total (in thousands) Financial Assets: Money market funds (1) $ 95,545 $ — $ — $ 95,545 $ 340 $ — $ — $ 340 Financial Liabilities: Interest rate swap (2) $ — $ 1,544 $ — $ 1,544 $ — $ 2,536 $ — $ 2,536 Warrant liabilities (3) $ — $ — $ — $ — $ — $ 252 $ — $ 252 There have been no transfers between hierarchy levels during the periods ending June 30, 2023 or December 31, 2022. (1) Money market funds are included within cash and cash equivalents and restricted cash in the Company’s condensed consolidated balance sheets. As short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that approximate fair value. The Company recorded interest income of $ 1.1 million and $ 1.8 million during the three and six months ended June 30, 2023 in relation to money market funds. (2) The fair value of the interest rate swap liability is recorded in other long-term liabilities on the condensed consolidated balance sheets. In November 2022 the Company entered into an interest rate swap contract ("VNB Swap") for the purpose of hedging the variability of interest expense and interest payments on the Company's long-term variable debt. The VNB Swap is carried at fair value which is based on a valuation model that utilizes interest rate yield curves and credit spreads observable in active markets as the significant inputs to the model. The Company considers credit risk associated with its own standing as well as the credit standing of any counterparties involved in the valuation of its financial instruments. (3) The total fair value and carrying value of the Company's liability warrants is recorded to warrant liabilities on the condensed consolidated balance sheets . All remaining liability warrants expired during the three months ended June 30, 2023.
Deferred Revenue	Deferred Revenue During the three months ended March 31, 2023, the Company terminated the loyalty program associated with dispensaries acquired with the acquisition of Harvest Health & Recreation, Inc. ("Harvest") in October 2021. As a result of the termination of the loyalty program at certain dispensaries, the Company recorded a reduction in the accrual of $ 4.7 million in revenue, net of discounts in the condensed consolidated statements of operations. As of June 30, 2023 and December 31, 2022, the loyalty liability totaled $ 5.1 million and $ 8.9 million , respectively, and is included in deferred revenue on the condensed consolidated balance sheets. Included within deferred revenue as of June 30, 2023 and December 31, 2022 are customer credit balances of $ 0.7 million and $ 0.5 million , respectively.
Impairment of Long-lived Assets	Impairment of Long-Lived Assets The Company reviews long-lived assets, including property and equipment, definite life intangible assets, and right-of-use assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. During the three months ended March 31, 2023, the Company determined that certain long-lived assets, including intangible assets, in Massachusetts were impaired due to the competitive environment in the Massachusetts cannabis industry. The Company utilized a cost approach for its impairment testing of property and equipment resulting in an impairment of $ 30.3 million, of which $ 27.6 million relates to discontinued operations and recorded to net loss from discontinued operations, net of tax benefit, and $ 2.7 million relates to continuing operations recorded in impairment and disposal of long-lived assets, net in the condensed consolidated statements of operations, respectively. During the three months ended June 30, 2023, the Company did not identify any events or changes in circumstances providing indication of impairment, other than the Company discontinuing its operations in Massachusetts in the normal course of business.
Impairment of Goodwill	Impairment of Goodwill The Company operates as one operating segment and reporting unit and therefore, evaluates goodwill for impairment as one singular reporting unit annually during the fourth quarter or more often when an event occurs, or circumstances indicate the carrying value may not be recoverable. The determination of the fair value of the reporting unit requires us to make significant estimates and assumptions. Due to the inherent uncertainty involved in making these estimates, actual future results could differ. Changes in assumptions regarding future results or other underlying assumptions could have a significant impact on the fair value of the reporting unit. The discounted cash flow model, or the income approach, reflects our estimates of future cash flows and other factors including estimates of future operating performance, including future revenue, long-term growth rates, gross margins, capital expenditures, discount rates and the probability of achieving the estimated cash flows, among others. In addition to the income approach, the Company also employs the market approach in its goodwill impairment testing. Under the market approach, the Company estimates the fair value based upon multiples of comparable public companies. Significant estimates in the market approach include identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, as well as assessing comparable market multiples in estimating the fair value of the reporting unit. During the three months ending March 31, 2023, the Company continued to experience a decline in its stock price resulting in the total market value of its common stock outstanding ("market capitalization") being less than the carrying value of the reporting unit. Management believes this decline in market value is due to a variety of factors, as further described below. In light of the circumstances and indicators of potential impairment described above, management performed an interim quantitative goodwill impairment test as of March 31, 2023. Management first considered whether any impairment was present for the Company’s long-lived assets, concluding that no such impairments were present after conducting an undiscounted cash flow recoverability test, except for in the Massachusetts market as detailed above. In comparing the estimated fair value of the reporting unit to its carrying value, the Company utilized a weighted average valuation using the discounted cash flow model and the market approach. The results of the Company’s interim test for impairment as of March 31, 2023 concluded that the estimated fair value of the reporting unit exceeded the carrying value, resulting in no impairment. During the three months ended June 30, 2023, the Company continued to experience a declined stock price resulting in the market capitalization being less than the carrying value of the reporting unit. The Company updated the March 31, 2023 valuation, as of June 30, 2023, with no impairment identified finding all inputs, including but not limited to future operating performance, gross margins, probability of achieving cash flows, and multiples of comparable public companies, either maintained consistency or trended positively for the three months ended June 30, 2023. Furthermore, the Company performed a sensitivity test on the income approach updating for the exit of the Massachusetts operations identifying the Massachusetts exit accretive to earnings as the Massachusetts assets were underperforming. However, the Company concluded the sustained stock price decline as a triggering event to perform an interim quantitative goodwill impairment test, as of June 30, 2023, specific to the stock price decline and resulting market capitalization of the Company. As the sole risk to the value of goodwill is the stock price, the Company concluded it most appropriate to transition to a market approach. The results of the Company’s interim test for impairment as of June 30, 2023, utilizing a market approach, indicated that the reporting unit's fair value fell below the carrying value. Based on the results of the goodwill impairment procedures, the Company recorded a $ 307.6 million goodwill impairment for the single reporting unit during the three months ended June 30, 2023. The Company finds the June 30, 2023 goodwill impairment is a result of the cannabis equity market including the reduced number of custodians to service cannabis equity holdings, negative investor sentiment due to lack of progress on federal reform, and more challenging macroeconomic conditions driving lower cannabis stock prices as of June 30, 2023. The Company finds this is not a negative indicator of historic or current operating results and not a negative indicator of future performance as the Company has taken steps to shed underperforming assets while focusing on cash conservation which is reflective in the results of operations as of June 30, 2023. Additionally, the resulting non-cash charge has no impact on the Company’s compliance with debt covenants, its cash flows, or available liquidity.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Schedule Of Fair Value Of Financial Instruments By Class	The fair values of financial instruments by class are as follows as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total (in thousands) Financial Assets: Money market funds (1) $ 95,545 $ — $ — $ 95,545 $ 340 $ — $ — $ 340 Financial Liabilities: Interest rate swap (2) $ — $ 1,544 $ — $ 1,544 $ — $ 2,536 $ — $ 2,536 Warrant liabilities (3) $ — $ — $ — $ — $ — $ 252 $ — $ 252 There have been no transfers between hierarchy levels during the periods ending June 30, 2023 or December 31, 2022. (1) Money market funds are included within cash and cash equivalents and restricted cash in the Company’s condensed consolidated balance sheets. As short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that approximate fair value. The Company recorded interest income of $ 1.1 million and $ 1.8 million during the three and six months ended June 30, 2023 in relation to money market funds. (2) The fair value of the interest rate swap liability is recorded in other long-term liabilities on the condensed consolidated balance sheets. In November 2022 the Company entered into an interest rate swap contract ("VNB Swap") for the purpose of hedging the variability of interest expense and interest payments on the Company's long-term variable debt. The VNB Swap is carried at fair value which is based on a valuation model that utilizes interest rate yield curves and credit spreads observable in active markets as the significant inputs to the model. The Company considers credit risk associated with its own standing as well as the credit standing of any counterparties involved in the valuation of its financial instruments. (3) The total fair value and carrying value of the Company's liability warrants is recorded to warrant liabilities on the condensed consolidated balance sheets . All remaining liability warrants expired during the three months ended June 30, 2023.

Accounts Receivable (Tables)

Accounts Receivable (Tables)	6 Months Ended
	Jun. 30, 2023
Receivables [Abstract]
Schedule of Accounts Receivable	Accounts receivable consisted of the following as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 (in thousands) Trade receivables $ 9,846 $ 8,482 Less: allowance for credit losses ( 2,833 ) ( 1,975 ) Accounts receivable, net $ 7,013 $ 6,507

Notes Receivable (Tables)

Notes Receivable (Tables)	6 Months Ended
	Jun. 30, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Schedule of Notes Receivable	Accounts receivable consisted of the following as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 (in thousands) Trade receivables $ 9,846 $ 8,482 Less: allowance for credit losses ( 2,833 ) ( 1,975 ) Accounts receivable, net $ 7,013 $ 6,507
Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Schedule of Notes Receivable	Notes receivable consisted of the following as of June 30, 2023 and December 31, 2022: June 30, December 31, Stated Interest Rate Maturity Date (in thousands) Promissory note acquired in October 2021 (1) $ 7,847 $ 8,205 7.50 % 11/9/2025 Promissory note dated November 15, 2021 (2) 4,830 4,602 9.75 % 11/14/2024 Notes receivable 12,677 12,807 Less: discount on notes receivable ( 68 ) ( 87 ) Total notes receivable, net of discount 12,609 12,720 Less: current portion of notes receivable ( 754 ) ( 728 ) Notes receivable, net $ 11,855 $ 11,992 (1) Interest and principal payments are due to the Company monthly. No payments are due to the Company until maturity. Interest is accrued monthly and added to the principal balance at each quarter end. The note is convertible to equity of the holder at the Company's option at any time prior to maturity. The note was issued with a nominal discount, resulting in an effective interest rate of 10.77 %.
Schedule of Stated Maturities of Notes Receivable	Stated maturities of the notes receivable are as follows as of June 30, 2023: Year Expected principal payments (in thousands) Six months ending December 31, 2023 $ 370 2024 5,614 2025 6,693 2026 — 2027 — Thereafter — Total 12,677 Less: discount on notes receivable ( 68 ) Total $ 12,609

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 30, 2023
Inventory Disclosure [Abstract]
Summary of Inventories	Inventories are comprised of the following as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 (in thousands) Raw material Cannabis plants $ 17,064 $ 21,523 Packaging and supplies 42,051 49,650 Total raw material 59,115 71,173 Work in process 134,167 158,448 Finished goods-unmedicated 5,915 7,323 Finished goods-medicated 53,588 39,561 Total inventories, net $ 252,785 $ 276,505

Property And Equipment (Tables)

Property And Equipment (Tables)	6 Months Ended
	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	As of June 30, 2023 and December 31, 2022, property and equipment consisted of the following: June 30, 2023 December 31, 2022 (in thousands) Land $ 34,485 $ 38,485 Buildings and improvements 514,711 497,493 Furniture and equipment 288,831 277,164 Vehicles 838 839 Total 838,865 813,981 Less: accumulated depreciation ( 163,269 ) ( 125,866 ) Total property and equipment 675,596 688,115 Construction in progress 33,059 55,145 Total property and equipment, net $ 708,655 $ 743,260
Schedule of Expenses Related to Property, Plant and Equipment	The Company incurred the following expense related to property and equipment during the three and six months ended June 30, 2023: Three Months Ended June 30, Six Months Ended June 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Capitalized interest Interest expense $( 214 ) $( 1,160 ) $( 795 ) $( 2,640 ) Depreciation expense Cost of goods sold and Depreciation and amortization 19,334 18,587 38,331 32,685 Total $ 19,120 $ 17,427 $ 37,536 $ 30,045 Three Months Ended June 30, Six Months Ended June 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Loss on impairment Impairments and disposals of long-lived assets, net $ — $ — $ 2,712 $ 330 Loss on disposal Impairments and disposals of long-lived assets, net 3,927 5,076 3,667 8,067 Total $ 3,927 $ 5,076 $ 6,379 $ 8,397

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets	The Company's definite-lived intangible assets consisted of the following as of June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Gross Carrying Amount Accumulated Amortization Net Book Value (in thousands) (in thousands) Licenses $ 1,046,544 $ 124,186 $ 922,358 $ 1,044,161 $ 89,367 $ 954,794 Trademarks 27,430 15,122 12,308 27,430 12,530 14,900 Internal use software 20,911 5,112 15,799 16,528 3,065 13,463 Tradenames 4,861 4,049 812 4,862 3,506 1,356 Customer relationships 3,535 3,352 183 3,536 3,252 284 Total $ 1,103,281 $ 151,821 $ 951,460 $ 1,096,517 $ 111,720 $ 984,797
Summary of Estimated Future Annual Amortization Expense Related to Intangible Assets	The following table outlines the estimated future amortization expense related to intangible assets as of June 30, 2023: Year Estimated (in thousands) Six Months Ending December 31, 2023 $ 40,592 2024 79,744 2025 76,677 2026 74,105 2027 71,604 Thereafter 608,738 $ 951,460

Held for Sale (Tables)

Held for Sale (Tables)	6 Months Ended
	Jun. 30, 2023
Disposal Group, Including Discontinued Operation, Assets [Abstract]
Summary of Held for Sale Assets	As of December 31, 2022, the Company had $ 14.5 million in assets held for sale which primarily consisted of property and equipment. (in thousands) Held for sale assets as of December 31, 2022 $ 14,521 Assets moved to held for sale 10,411 Non-cash settlement ( 2,481 ) Impairments ( 1,994 ) Assets sold ( 3,268 ) Held for sale assets as of June 30, 2023 $ 17,189 Held for sale liabilities as of December 31, 2022 $ — Liabilities moved to held for sale ( 1,997 ) Liabilities settled associated with held for sale assets 1,997 Held for sale liabilities as of June 30, 2023 $ —

Notes Payable (Tables)

Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Notes Payable	As of June 30, 2023 and December 31, 2022, notes payable consisted of the following: June 30, 2023 December 31, 2022 Stated Interest Rate Effective Interest Rate Maturity Date Net Book Value of Collateral (in thousands) Promissory notes dated December 21, 2022 (1) $ 70,839 $ 71,500 7.53 % (4) 7.86 % 1/1/2028 $ 156,667 Promissory note dated December 22, 2022 (2) 18,687 18,900 7.30 % (4) 7.38 % 12/22/2032 $ 9,375 Promissory notes dated October 1, 2021 (3) 5,856 6,095 8.14 % (4) 8.29 % 10/1/2027 $ 11,555 Promissory note dated December 22, 2022 5,500 5,500 10.00 % (4) 10.00 % 12/22/2023 (5) Promissory notes acquired in October 2021 1,778 5,338 (6) (4) (6) (6) (6) Promissory note of consolidated variable-interest entity dated February 1, 2022 1,045 1,200 8.00 % (4) 8.00 % 12/31/2025 — Total notes payable 103,705 108,533 Less: debt discount ( 1,671 ) ( 1,833 ) Less: current portion of notes payable ( 9,076 ) ( 12,453 ) Notes payable, net (7) $ 92,958 $ 94,247 (1) In connection with the closing of these four promissory notes, the Company entered into an interest rate swap to fix the interest rate at 7.53 % for the term of the notes. See Note 23 in the 2022 Form 10-K fo r further details. These promissory notes contain customary restrictive covenants pertaining to our management and operations, including, among other things, limitations on the amount of debt that may be incurred and the ability to pledge assets, among other things, as well as financial covenant requirements, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements, fixed charge ratio coverage, and liquidity covenant test. The covenants commence on June 30, 2023 and are measured semi-annually, except for certain covenants which were measured starting as of December 31, 2022. In May 2023, the Company amended the terms of the agreement in respect to the covenant requirements, excluding balloon payments from certain covenant calculations. (2) Promissory note bears interest at 7.30 % per annum until December 21, 2027. Thereafter, interest will accrue at a rate equal to the five-year treasury rate in effect as of December 12, 2027 plus 3.50 %. The promissory note contains customary restrictive covenants pertaining to our operations, including, among other things, limitations on the amount of debt and subsidiary debt that may be incurred and the ability to pledge assets, as well as financial covenant requirements, among other things, that the Company comply with certain indebtedness to consolidated EBITDA (as defined) requirements, covenant to liquidity and debt principal test, and a global debt service coverage ratio. The covenants commence on December 31, 2022 and December 31, 2023 and are measured annually. (3) On November 15, 2022 , the Company closed on the refinancing of our promissory notes dated October 1, 2021 to extend the maturity date by five years and fix the interest rate at 8.14 %. During the three months ended March 31, 2023, the Company determined to reposition the collateralized assets to held for sale as part of its continued efforts to optimize our assets and resources in the markets in which it serves. The Company expects to sell the assets, which primarily consist of property and equipment, within the near-term. (4) Interest payments are due monthly . (5) Promissory note is secured by the acquired membership interest in Formula 420 Cannabis LLC. See Note 4 in the 2022 Form 10-K fo r further details . (6) Seven promissory notes were acquired during the year ending December 31, 2021. Interest rates range from 0.00 % to 5.50 % , with a weighted average interest rate of 5.38 % as of June 30, 2023. Maturity dates range from July 2023 to April 2026 . Of the seven acquired promissory notes, three remain outstanding as of June 30, 2023. The three notes are secured by various assets that approximate the value of the underlying notes of $ 1.8 million as of June 30, 2023 . (7) In addition to the notes payable listed in the above table, the Company entered into a letter of credit in October 2022 for up to $ 1.5 million, for which there have been no draws as of June 30, 2023 . The letter of credit is payable on demand, has an interest rate of 6.25 %, and must be drawn on by October 2023 or will expire.
Schedule of Stated Maturities of Notes Payable	As of June 30, 2023, stated maturities of notes payable are as follows: (in thousands) Six months ended December 31, 2023 $ 7,788 2024 3,232 2025 3,888 2026 3,044 2027 69,352 Thereafter 16,401 Total $ 103,705

Private Placement Notes (Tables

Private Placement Notes (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Private Placement Notes Payable	As of June 30, 2023 and December 31, 2022, private placement notes payable consisted of the following: June 30, 2023 December 31, 2022 Stated Interest Rate Effective Interest Rate Maturity Date (in thousands) 2026 Notes - Tranche One $ 350,000 $ 350,000 8.00 % 8.52 % 10/6/2026 2026 Notes - Tranche Two 75,000 75,000 8.00 % 8.43 % 10/6/2026 June Notes 70,000 70,000 9.75 % 13.32 % 6/11/2024 November Notes 60,000 60,000 9.75 % 13.43 % 6/11/2024 Total private placement notes 555,000 555,000 Less: Unamortized debt discount and issuance costs ( 10,534 ) ( 13,336 ) Less: current portion of private placement notes, net ( 125,861 ) — Private placement notes, net $ 418,605 $ 541,664
Summary of Scheduled Maturities of Principal Portion of Private Placement Notes, Outstanding	Stated maturities of the principal portion of private placement notes outstanding as of June 30, 2023, are as follows: Year (in thousands) Six months ending December 31, 2023 $ — 2024 130,000 2025 — 2026 425,000 2027 — Thereafter — Total private placement notes $ 555,000

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Components of Lease Cost	The following table provides the components of lease cost recognized within the condensed consolidated statements of operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended Six Months Ended June 30, Statement of Operations 2023 2022 2023 2022 (in thousands) Operating lease cost Cost of goods sold, sales and marketing, general and administrative $ 5,289 $ 5,515 $ 10,200 $ 10,979 Finance lease cost: Amortization of lease assets Cost of goods sold and Depreciation and amortization 2,578 2,581 5,353 4,986 Interest on lease liabilities Interest expense 1,613 1,568 3,221 3,056 Finance lease cost 4,191 4,149 8,574 8,042 Variable lease cost Cost of goods sold, sales and marketing, general and administrative 2,450 1,878 4,716 3,792 Short term lease expense Cost of goods sold, sales and marketing, general and administrative 166 156 369 255 Total lease cost $ 12,096 $ 11,698 $ 23,859 $ 23,068
Schedule of Other Information Related to Operating and Finance Leases	Other information related to operating and finance lease s is as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 5,005 $ 5,271 $ 10,067 $ 10,166 Operating cash flows from finance leases $ 1,612 $ 1,559 $ 3,267 $ 3,047 Financing cash flows from finance leases $ 1,748 $ 1,721 $ 3,671 $ 3,075 ASC 842 lease additions and modifications: Operating leases $ 6,406 $ 2,404 $ 11,008 $ 11,970 Finance leases $ 173 $ 12,112 $ 116 $ 18,413 June 30, 2023 December 31, 2022 Weighted average discount rate: Operating leases 10.00 % 9.29 % Finance leases 9.00 % 8.66 % Weighted average remaining lease term (in years): Operating leases 9.1 8.3 Finance leases 7.7 7.8
Schedule of Future Minimum Lease Payments under Non-cancellable Leases	Future minimum lease payments under the Company's non-cancellable leases as of June 30, 2023 are as follows: Operating Leases Finance Leases (in thousands) Six months ending December 31, 2023 $ 9,719 $ 6,831 2024 20,420 13,680 2025 20,359 13,470 2026 19,708 12,605 2027 19,103 11,703 Thereafter 75,826 43,358 Total undiscounted lease liabilities 165,135 101,647 Less: Interest ( 54,736 ) ( 29,436 ) Total present value of minimum lease payments 110,399 72,211 Lease liabilities- current portion ( 9,668 ) ( 7,595 ) Lease liabilities $ 100,731 $ 64,616

Construction Finance Liabilit_2

Construction Finance Liabilities (Tables)	6 Months Ended
	Jun. 30, 2023
Construction Finance Liability [Abstract]
Schedule of Future minimum Lease Payments for Construction Finance Liabilities	Future minimum lease payments for the construction finance liabilities as of June 30, 2023, are as follows: Year (in thousands) Six months ending December 31, 2023 $ 8,325 2024 17,043 2025 17,521 2026 18,013 2027 18,519 Thereafter 302,424 Total future payments 381,845 Less: Interest ( 243,582 ) Total present value of minimum payments 138,263 Construction finance liabilities - current portion ( 1,324 ) Construction finance liabilities $ 136,939

Equity (Tables)

Equity (Tables)	6 Months Ended
	Jun. 30, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Warrants Outstanding and Exercisable	Number Weighted average exercise price Weighted average Outstanding and exercisable as of January 1, 2023 1,679 $ 1,125 0.31 Granted — — — Exercised — — — Expired ( 1,679 ) 1,125 — Outstanding and exercisable as of June 30, 2023 — $ — —
Schedule of Share-Based Compensation Expense	The Company recorded share-based compensation for stock options as follows: Three Months Ended June 30, Six Months Ended June 30, Statement of operations location 2023 2022 2023 2022 (in thousands) Cost of goods sold $ 19 $ ( 56 ) $ 35 $ 70 General and administrative ( 275 ) 2,195 469 3,936 Sales and marketing 13 439 33 729 Total share-based compensation expense $ ( 243 ) $ 2,578 $ 537 $ 4,735
Schedule of Stock Option Activity	The number and weighted-average exercise prices and remaining contractual life of options as of June 30, 2023 were as follows: Number of options Weighted average exercise price Weighted average remaining contractual life (Yrs.) Aggregate intrinsic value Outstanding, January 1, 2023 3,177,815 $ 25.96 5.41 $ — Granted — — Exercised — — Forfeited ( 334,864 ) 30.29 Outstanding, June 30, 2023 2,842,951 $ 25.45 4.66 $ — Exercisable, June 30, 2023 2,222,348 $ 25.67 3.59 $ —
Schedule of Restricted Stock Units Activity	The following is a summary of RSU activity for the six months ended June 30, 2023 Number of Weighted average Unvested balance as of January 1, 2023 720,707 $ 22.36 Granted — Vested — Forfeited ( 102,064 ) 23.03 Unvested balance as of June 30, 2023 618,643 $ 22.21
RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Schedule of Restricted Stock Units Activity	The Company recorded share-based compensation for RSUs as follows: Three Months Ended June 30, Six Months Ended June 30, Statement of operations location 2023 2022 2023 2022 (in thousands) Cost of goods sold $ 41 $ 258 $ 260 $ 458 General and administrative 601 2,567 1,920 4,462 Sales and marketing 76 300 159 612 Total share-based compensation expense $ 718 $ 3,125 $ 2,339 $ 5,532

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of Reconciliation For Calculation of Basic And Diluted Earnings Per Share	The following is a reconciliation for the calculation of basic and diluted earnings per share: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Numerator (in thousands, except share and per share amounts) Continuing operations Net loss from continuing operations $ ( 342,304 ) $ ( 18,787 ) $ ( 376,626 ) $ ( 45,831 ) Less: Net loss attributable to non-controlling interest ( 2,353 ) ( 1,530 ) ( 3,337 ) ( 2,037 ) Net loss from continuing operations available to common shareholders of Trulieve Cannabis Corp. $ ( 339,951 ) $ ( 17,257 ) $ ( 373,289 ) $ ( 43,794 ) Discontinued operations Net loss from discontinued operations $ ( 64,568 ) $ ( 5,234 ) $ ( 95,877 ) $ ( 10,672 ) Less: Net loss attributable to non-controlling interest ( 670 ) — ( 1,193 ) — Net loss from discontinued operations excluding non-controlling interest $ ( 63,898 ) $ ( 5,234 ) $ ( 94,684 ) $ ( 10,672 ) Denominator Weighted average number of common shares outstanding - Basic and diluted 189,054,359 187,174,176 188,976,834 187,124,886 Loss per Share - Continuing operations Basic and diluted loss per share $ ( 1.80 ) $ ( 0.09 ) $ ( 1.98 ) $ ( 0.23 ) Loss per Share - Discontinued operations Basic and diluted loss per share $ ( 0.34 ) $ ( 0.03 ) $ ( 0.50 ) $ ( 0.06 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Shares which have been excluded from diluted per share amounts because their effect would have been anti-dilutive are as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Stock options 2,842,951 3,465,639 2,985,093 3,547,090 Restricted share units 618,643 1,035,762 655,474 1,057,043 Warrants 9,496 767,500 93,444 2,201,764

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Summary of Income Tax Expense and Effective Tax Rate	The following table summarizes the Company’s income tax expense and effective tax rate for the three and six months ended June 30, 2023 and 2022. Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) (Loss) Income before provision for income taxes $ ( 308,277 ) $ 26,455 $ ( 307,142 ) $ 42,553 Provision for income taxes $ 34,027 $ 45,242 $ 69,484 $ 88,384 Effective tax rate ( 11 %) 171 % ( 23 %) 208 %

Discontinued Operations (Tables

Discontinued Operations (Tables)	6 Months Ended
	Jun. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Summary of Assets and Liabilities, Loss from Discontinued Operations and Cash Flow Including Continuing from Discontinued Operations	The assets and liabilities associated with discontinued operations consisted of the following as June 30, 2023 and December 31, 2022: June 30, 2023 December 31, 2022 (in thousands) Assets associated with discontinued operations Cash $ 1,835 $ 5,702 Accounts receivable, net 2,744 2,936 Inventories, net 3,230 21,310 Income tax receivable 2,718 2,267 Prepaids expenses and other current assets 947 1,486 Deferred tax asset — 766 Property and equipment, net — 53,687 Right of use assets - operating, net — 1,769 Right of use assets - finance, net — 5,736 Intangible assets, net — 27,849 Other assets 2,013 2,638 Total assets associated with discontinued operations $ 13,487 $ 126,146 Liabilities associated with discontinued operations Accounts payable and accrued liabilities $ 1,120 $ 1,617 Deferred revenue — 109 Operating lease liabilities - current portion 70 93 Finance lease liabilities - current portion 427 456 Construction finance liability - current portion 1,794 — Operating lease liabilities 14,686 16,428 Finance lease liabilities 2,829 5,890 Construction finance liability 25,237 45,217 Other long-term liabilities 156 154 Total liabilities associated with discontinued operations $ 46,319 $ 69,964 The following table summarizes the Company's income (loss) from discontinued operations for the three and six months ended June 30, 2023 and 2022. The gain and loss resulting from the forgiveness of intercompany payables has been eliminated in consolidation. Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Revenues, net of discounts $ 4,472 $ 6,444 $ 8,347 $ 14,231 Cost of goods sold 22,872 7,663 26,972 17,155 Gross margin ( 18,400 ) ( 1,219 ) ( 18,625 ) ( 2,924 ) Expenses: Operating expenses 1,994 2,984 4,382 6,049 Impairment and disposal of long-lived assets, net 41,639 — 69,275 — Total Expenses 43,633 2,984 73,657 6,049 Income (loss) from operations ( 62,033 ) ( 4,203 ) ( 92,282 ) ( 8,973 ) Other (expense) income: Interest expense ( 1,589 ) ( 1,534 ) ( 3,178 ) ( 3,058 ) Other income, net — 30 22 60 Total other expense, net ( 1,589 ) ( 1,504 ) ( 3,156 ) ( 2,998 ) Loss before provision for income taxes ( 63,622 ) ( 5,707 ) ( 95,438 ) ( 11,971 ) Income tax (provision) benefit ( 946 ) 473 ( 439 ) 1,299 Net loss from discontinued operations, net of tax (provision) benefit ( 64,568 ) ( 5,234 ) ( 95,877 ) ( 10,672 ) Less: Net loss attributable to non-controlling interest from discontinued operations ( 670 ) — ( 1,193 ) — Net loss from discontinued operations excluding non-controlling interest $ ( 63,898 ) $ ( 5,234 ) $ ( 94,684 ) $ ( 10,672 ) The condensed consolidated statements of cash flows include continuing operations and discontinued operations. The following table summarizes the depreciation of long-lived assets, amortization of long-lived assets, and capital expenditures of discontinued operations for the three and six months ended June 30, 2023 and 2022. Six Months Ended June 30, 2023 2022 Depreciation $ 2,917 $ 2,875 Amortization $ 535 $ 2,795 Purchases of property plant and equipment $ 67 $ 685 Loss on impairment of long-lived assets $ 69,275 $ — Other noncash investing and financing activities Noncash partial extinguishment of construction finance liability $ 18,486 $ —
Schedule of Future minimum Lease Payments for Construction Finance Liability	Future minimum lease payments for the construction finance liabilities as of June 30, 2023, are as follows: Year (in thousands) Six months ending December 31, 2023 $ 8,325 2024 17,043 2025 17,521 2026 18,013 2027 18,519 Thereafter 302,424 Total future payments 381,845 Less: Interest ( 243,582 ) Total present value of minimum payments 138,263 Construction finance liabilities - current portion ( 1,324 ) Construction finance liabilities $ 136,939
Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Schedule of Future minimum Lease Payments for Construction Finance Liability	Future minimum lease payments for the construction finance liability as of June 30, 2023, are as follows: Year (in thousands) Six months ending December 31, 2023 $ 2,682 2024 5,455 2025 5,619 2026 5,788 2027 5,961 Thereafter 18,427 Total future payments 43,932 Less: Interest ( 16,901 ) Total present value of minimum payments 27,031 Construction finance liability - current portion ( 1,794 ) Construction finance liability $ 25,237

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Assets and Liabilities of Company's VIEs	The following table presents the summarized assets and liabilities of the Company’s VIEs in which the Company does not hold a majority interest as of June 30, 2023 and December 31, 2022. The assets and liabilities in the table below include third-party assets and liabilities of our VIEs only and exclude intercompany balances that eliminate in consolidation as included on our condensed consolidated balance sheets. June 30, 2023 December 31, 2022 (in thousands) Current assets: Cash $ 6,703 $ 7,349 Accounts receivable, net 1,208 597 Inventories, net 8,359 7,590 Prepaids and other current assets 514 46 Total current assets 16,784 15,582 Property and equipment, net 27,923 25,994 Right of use asset - operating, net 2,817 — Right of use asset - finance, net 275 224 Intangible assets, net 17,830 17,947 Other assets 147 344 Total assets $ 65,776 $ 60,091 Current liabilities: Accounts payable and accrued liabilities $ 2,188 $ 3,713 Income tax payable 2,538 1,615 Deferred revenue 1 6 Finance lease liability - current portion 55 41 Total current liabilities 4,782 5,375 Notes payable 1,045 1,200 Operating lease liability 2,892 — Finance lease liability 229 185 Deferred tax liabilities 3,663 4,101 Other long-term liabilities 796 625 Total liabilities $ 13,407 $ 11,486

Related Parties (Tables)

Related Parties (Tables)	6 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
Right of Use Assets and Lease Liabilities under ASC 842	As of June 30, 2023, and December 31, 2022, under ASC 842, the Company had the following related party operating leases on the condensed consolidated balance sheets: As of June 30, 2023 As of December 31, 2022 (in thousands) Right-of-use assets, net $ 755 $ 820 Lease liabilities: Lease liabilities - current portion $ 121 $ 113 Lease liabilities 679 751 Total related parties lease liabilities $ 800 $ 864

Revenue Disaggregation (Tables)

Revenue Disaggregation (Tables)	6 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Net Revenues Comprised	Net revenues are comprised of the following for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Retail $ 271,888 $ 297,603 $ 546,733 $ 587,645 Wholesale, licensing, and other 9,907 16,236 20,276 36,755 Revenue, net of discounts $ 281,795 $ 313,839 $ 567,009 $ 624,400

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Settlement of previous litigation	$ 22,500			$ 22,500
Litigation settlement amount paid in cash	17,000
Litigation settlement amount relieved	5,500			5,500
Loyalty liability	5,100			5,100		$ 8,900
Customer credit balance in deferred revenue	700			700		500
Reduction in accrual of revenue due to termination of loyalty program		$ 4,700
Impairments and disposals of long-lived assets, net	3,310		$ 5,055	6,689	$ 21,516
Impairment of goodwill	$ 307,590		$ 0	307,590	$ 0
Fair value liabilities transfers amount				$ 0		$ 0
Property and Equipment and Intangible Assets [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairments and disposals of long-lived assets, net		30,300
Discontinued Operations | Property and Equipment and Intangible Assets [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairments and disposals of long-lived assets, net		27,600
Continuing Operations | Property and Equipment and Intangible Assets [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairments and disposals of long-lived assets, net		$ 2,700

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule Of Fair Value Of Financial Instruments By Class (Details) - USD ($) $ in Thousands		Jun. 30, 2023	Dec. 31, 2022
Money Market Funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure		$ 95,545	$ 340	[1]
Money Market Funds | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents, fair value disclosure		95,545	340	[1]
Interest Rate Swap
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure		1,544	2,536	[2]
Interest Rate Swap | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure		$ 1,544	2,536	[2]
Warrant Liability
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	[3]		252
Warrant Liability | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial liabilities fair value disclosure	[3]		$ 252
[1] Money market funds are included within cash and cash equivalents and restricted cash in the Company’s condensed consolidated balance sheets. As short-term, highly liquid investments readily convertible to known amounts of cash, the Company’s money market funds have carrying values that approximate fair value. The Company recorded interest income of $ 1.1 million and $ 1.8 million during the three and six months ended June 30, 2023 in relation to money market funds. The fair value of the interest rate swap liability is recorded in other long-term liabilities on the condensed consolidated balance sheets. In November 2022 the Company entered into an interest rate swap contract ("VNB Swap") for the purpose of hedging the variability of interest expense and interest payments on the Company's long-term variable debt. The VNB Swap is carried at fair value which is based on a valuation model that utilizes interest rate yield curves and credit spreads observable in active markets as the significant inputs to the model. The Company considers credit risk associated with its own standing as well as the credit standing of any counterparties involved in the valuation of its financial instruments. The total fair value and carrying value of the Company's liability warrants is recorded to warrant liabilities on the condensed consolidated balance sheets . All remaining liability warrants expired during the three months ended June 30, 2023.

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule Of Fair Value Of Financial Instruments By Class (Parenthetical) (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023
Accounting Policies [Abstract]
Interest income	$ 1.1	$ 1.8

Accounts Receivable - Schedule

Accounts Receivable - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Trade receivables	$ 9,846	$ 8,482
Less: allowance for credit losses	(2,833)	(1,975)
Accounts receivable, net	$ 7,013	$ 6,507

Notes Receivable - Schedule of

Notes Receivable - Schedule of Notes Receivable (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 12,677	$ 12,807
Less: discount on notes receivable	(68)	(87)
Total notes receivable, net of discounts	12,609	12,720
Less: current portion of notes receivable	(754)	(728)
Notes receivable, net	11,855	11,992
Promissory Note Acquired in October 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 7,847	$ 8,205
Stated Interest Rate	7.50%	7.50%
Maturity Date	Nov. 09, 2025	Nov. 09, 2025
Promissory Note Dated November 15, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 4,830	$ 4,602
Stated Interest Rate	9.75%	9.75%
Maturity Date	Nov. 14, 2024	Nov. 14, 2024

Notes Receivable - Schedule o_2

Notes Receivable - Schedule of Notes Receivable (Parenthetical) (Details)	Jun. 30, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Effective Interest Rate	10.77%

Notes Receivable - Additional I

Notes Receivable - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Other income
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 0.3	$ 0.3	$ 0.6	$ 0.7

Notes Receivable - Schedule o_3

Notes Receivable - Schedule of Stated Maturities of Notes Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Six months ending December 31, 2023	$ 370
2024	5,614
2025	6,693
2026	0
2027	0
Thereafter	0
Total	12,677	$ 12,807
Less: discount on notes receivable	(68)	(87)
Total notes receivable, net of discounts	$ 12,609	$ 12,720

Inventories - Summary of Invent

Inventories - Summary of Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Inventory [Line Items]
Total Raw Material	$ 59,115	$ 71,173
Work in process	134,167	158,448
Total inventories, net	252,785	276,505
Cannabis Plants
Inventory [Line Items]
Total Raw Material	17,064	21,523
Packaging and Supplies
Inventory [Line Items]
Total Raw Material	42,051	49,650
Unmedicated
Inventory [Line Items]
Finished Goods	5,915	7,323
Medicated
Inventory [Line Items]
Finished Goods	$ 53,588	$ 39,561

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	$ 838,865	$ 813,981
Less: accumulated depreciation	(163,269)	(125,866)
Total property and equipment	675,596	688,115
Total property and equipment, net	708,655	743,260
Land
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	34,485	38,485
Buildings and Improvements
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	514,711	497,493
Furniture and Equipment
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	288,831	277,164
Vehicles
Property Plant And Equipment [Line Items]
Property and Equipment, Gross	838	839
Construction In Progress
Property Plant And Equipment [Line Items]
Construction in progress	$ 33,059	$ 55,145

Property and Equipment - Sche_2

Property and Equipment - Schedule of Expenses Related to Property, Plant and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Property, Plant and Equipment [Line Items]
Interest expense	$ (214)	$ (1,160)	$ (795)	$ (2,640)
Cost of goods sold and Depreciation and amortization	19,334	18,587	38,331	32,685
Total	19,120	17,427	37,536	30,045
Gain (loss) on disposal of long-lived assets			45,800
Impairments and disposals of long-lived assets, net
Property, Plant and Equipment [Line Items]
Impairment of property and equipment	0	0	2,712	330
Gain (loss) on disposal of long-lived assets	3,927	5,076	3,667	8,067
Loss on impairment and disposal of property and equipment	$ 3,927	$ 5,076	$ 6,379	$ 8,397

Intangible Assets - Summary of

Intangible Assets - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,103,281	$ 1,096,517
Accumulated Amortization	151,821	111,720
Net Book Value	951,460	984,797
Licenses
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,046,544	1,044,161
Accumulated Amortization	124,186	89,367
Net Book Value	922,358	954,794
Trademarks
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	27,430	27,430
Accumulated Amortization	15,122	12,530
Net Book Value	12,308	14,900
Internal Use Software
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	20,911	16,528
Accumulated Amortization	5,112	3,065
Net Book Value	15,799	13,463
Tradenames
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	4,861	4,862
Accumulated Amortization	4,049	3,506
Net Book Value	812	1,356
Customer Relationships
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,535	3,536
Accumulated Amortization	3,352	3,252
Net Book Value	$ 183	$ 284

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 20.2	$ 20.5	$ 40.1	$ 41.1
Gain on sale of intangible assets	$ 3		$ 3
Weighted average amortization period remaining for intangible assets	12 years 10 months 24 days		12 years 10 months 24 days

Intangible Assets - Summary o_2

Intangible Assets - Summary of Estimated Future Annual Amortization Expense Related to Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Six Months Ending December 31, 2023	$ 40,592
2024	79,744
2025	76,677
2026	74,105
2027	71,604
Thereafter	608,738
Net Book Value	$ 951,460	$ 984,797

Held for Sale - Additional Info

Held for Sale - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
loss on the impairment and disposal of held for sale assets	$ 1.8		$ 2.6	$ 2.6
Maximum
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
loss on the impairment and disposal of held for sale assets		$ 0.1
Prepaid Expenses and Other Current Assets
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	$ 17.2		$ 17.2		$ 14.5

Held for Sale - Summary of Held

Held for Sale - Summary of Held for Sale Assets (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Disposal Group, Including Discontinued Operation, Assets [Abstract]
Held for sale assets, Beginning balance	$ 14,521
Assets moved to held for sale	10,411
Non-cash settlement	(2,481)
Impairments	(1,994)
Assets sold	(3,268)
Held for sale assets, Ending balance	17,189
Liabilities moved to held for sale	(1,997)
Liabilities settled associated with held for sale assets	$ 1,997

Notes Payable - Schedule of Not

Notes Payable - Schedule of Notes Payable, Net (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Nov. 15, 2022
Notes Payable [Line Items]
Total notes payable	$ 103,705	$ 108,533
Less: debt discount, current	(1,671)	(1,833)
Less: current portion of notes payable	(9,076)	(12,453)
Notes payable, net	$ 92,958	94,247
Effective Interest Rate	10.77%
Promissory notes dated December 21, 2022
Notes Payable [Line Items]
Total notes payable	$ 70,839	71,500
Stated Interest Rate	7.53%
Effective Interest Rate	7.86%
Debt Instrument, Maturity Date	Jan. 01, 2028
Net Book Value Of Collateral	$ 156,667
Promissory note dated December 22, 2022
Notes Payable [Line Items]
Total notes payable	$ 18,687	18,900
Stated Interest Rate	7.30%
Effective Interest Rate	7.38%
Debt Instrument, Maturity Date	Dec. 22, 2032
Net Book Value Of Collateral	$ 9,375
Promissory notes dated October 1, 2021
Notes Payable [Line Items]
Total notes payable	$ 5,856	6,095
Stated Interest Rate	8.14%		8.14%
Effective Interest Rate	8.29%
Debt Instrument, Maturity Date	Oct. 01, 2027
Net Book Value Of Collateral	$ 11,555
Promissory note dated December 22, 2022
Notes Payable [Line Items]
Total notes payable	$ 5,500	5,500
Stated Interest Rate	10%
Effective Interest Rate	10%
Debt Instrument, Maturity Date	Dec. 22, 2023
Promissory notes acquired in Harvest Acquisition
Notes Payable [Line Items]
Total notes payable	$ 1,778	5,338
Promissory note of consolidated variable-interest entity dated February 1, 2022
Notes Payable [Line Items]
Total notes payable	$ 1,045	$ 1,200
Stated Interest Rate	8%
Effective Interest Rate	8%
Debt Instrument, Maturity Date	Dec. 31, 2025

Notes Payable - Schedule of N_2

Notes Payable - Schedule of Notes Payable (Parenthetical) (Details) $ in Millions		1 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended
	Nov. 15, 2022	Oct. 31, 2021	Mar. 31, 2023 PromissoryNote	Jun. 30, 2023 USD ($)	Dec. 31, 2021 PromissoryNote	Oct. 31, 2022 USD ($)
Notes Payable [Line Items]
Effective Interest Rate				10.77%
Letter of credit | $						$ 1.5
Letter of credit interest rate		6.25%
Promissory notes dated December 21, 2022
Notes Payable [Line Items]
Notes payable, commencement date				Dec. 21, 2022
Debt instrument, frequency of interest payment				monthly
Notes payable, annual interest rate				7.53%
Effective Interest Rate				7.86%
Promissory note dated December 22, 2022
Notes Payable [Line Items]
Notes payable, commencement date				Dec. 22, 2022
Debt instrument, frequency of interest payment				monthly
Notes payable, annual interest rate				7.30%
Effective Interest Rate				7.38%
Debt instrument, interest rate, basis for effective rate				Promissory note bears interest at 7.30% per annum until December 21, 2027. Thereafter, interest will accrue at a rate equal to the five-year treasury rate in effect as of December 12, 2027 plus 3.50%.
Five-year treasury rate in effect, plus percentage				3.50%
Promissory notes dated October 1, 2021
Notes Payable [Line Items]
Notes payable, commencement date	Oct. 01, 2021			Oct. 01, 2021
Refinancing debt closure date	Nov. 15, 2022
Debt instrument, frequency of interest payment				monthly
Notes payable, annual interest rate	8.14%			8.14%
Refinancing debt instrument term	5 years
Notes payable, maturity description	extend the maturity date by five years
Effective Interest Rate				8.29%
Promissory note dated December 22, 2022
Notes Payable [Line Items]
Notes payable, commencement date				Dec. 22, 2022
Debt instrument, frequency of interest payment				monthly
Notes payable, annual interest rate				10%
Effective Interest Rate				10%
Promissory notes acquired in Harvest Acquisition
Notes Payable [Line Items]
Debt instrument, frequency of interest payment				monthly
Number of promissory notes, acquired | PromissoryNote					7
Number of remaining outstanding promissory notes | PromissoryNote			3
Debt instrument description				Of the seven acquired promissory notes, three remain outstanding as of June 30, 2023. The three notes are secured by various assets that approximate the value of the underlying notes of $1.8 million as of June 30, 2023.
Promissory notes, secured of underlying notes | $				$ 1.8
Notes payable, maturity month and year range, start				2023-07
Notes payable, maturity month and year range, end				2026-04
Promissory notes acquired in Harvest Acquisition | Minimum
Notes Payable [Line Items]
Notes payable, annual interest rate				0%
Promissory notes acquired in Harvest Acquisition | Maximum
Notes Payable [Line Items]
Notes payable, annual interest rate				5.50%
Promissory notes acquired in Harvest Acquisition | Weighted Average
Notes Payable [Line Items]
Notes payable, annual interest rate				5.38%
Promissory note of consolidated variable-interest entity dated February 1, 2022
Notes Payable [Line Items]
Notes payable, commencement date				Feb. 01, 2022
Debt instrument, frequency of interest payment				monthly
Notes payable, annual interest rate				8%
Effective Interest Rate				8%

Notes Payable - Additional Info

Notes Payable - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Debt Disclosure [Abstract]
Notes Payables Interest Expense Incurred	$ 2.1	$ 0.2	$ 4.2	$ 0.3
Notes payable, accretion expense	$ 0.1	$ 0.1	$ 0.2	$ 0.1

Notes Payable - Schedule of Sta

Notes Payable - Schedule of Stated Maturities of Notes Payable (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Six months ended December 31, 2023	$ 7,788
2024	3,232
2025	3,888
2026	3,044
2027	69,352
Thereafter	16,401
Total notes payable	$ 103,705	$ 108,533

Private Placement Notes - Addit

Private Placement Notes - Additional Information (Details)			3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 28, 2022 USD ($)	Oct. 06, 2021 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2019 USD ($) Warrant $ / shares shares
Debt Instrument [Line Items]
Debt instrument, interest rate			10.77%		10.77%
Accretion expense			$ 1,400,000	$ 1,300,000	$ 2,800,000	$ 2,500,000
Interest Expense Incurred			$ 13,000,000	$ 13,500,000	25,900,000	25,800,000
Repaid principal amount					$ 4,828,000	$ 2,486,000
June Notes
Debt Instrument [Line Items]
Debt instrument term							5 years
Debt instrument face amount							$ 70,000,000
Stated Interest Rate			9.75%		9.75%
Warrants to purchase of shares | shares							1,470,000
Warrants exercise price | (per share) | $ / shares							$ 13.47
Notes payable, annual interest rate			9.75%		9.75%
Debt instrument, interest rate			13.32%		13.32%
Warrants exercise price | $ / shares							$ 13.47
Debt instrument, maturity date					Jun. 11, 2024
November Notes
Debt Instrument [Line Items]
Debt instrument term							5 years
Debt instrument face amount							$ 60,000,000
Stated Interest Rate			9.75%		9.75%
Warrants to purchase of shares | shares							1,560,000
Warrants exercise price | (per share) | $ / shares							$ 980
Denominations value of note issued							$ 1,000
Number of warrants in denominations | Warrant							26
Debt instrument exercised period							3 years
Notes payable, annual interest rate			9.75%		9.75%
Debt instrument, interest rate			13.43%		13.43%
Warrants exercise price | $ / shares							$ 980
Debt instrument, maturity date					Jun. 11, 2024
2026 Notes - Tranche One
Debt Instrument [Line Items]
Stated Interest Rate		8%	8%		8%
Notes payable, annual interest rate		8%	8%		8%
Debt instrument, interest rate			8.52%		8.52%
Gross proceeds from private placement		$ 350,000,000
Net proceeds from private placement		$ 342,600,000
Debt instrument, maturity date					Oct. 06, 2026
2026 Notes - Tranche Two
Debt Instrument [Line Items]
Stated Interest Rate	8%		8%		8%
Notes payable, annual interest rate	8%		8%		8%
Debt instrument, interest rate			8.43%		8.43%
Gross proceeds from private placement	$ 76,900,000
Net proceeds from private placement	$ 75,600
Debt instrument, maturity date					Oct. 06, 2026

Private Placement Notes - Assum

Private Placement Notes - Assumptions Used in Black-Scholes Option Pricing Model for Warrants (Details)	Dec. 31, 2019 $ / shares
June Notes
Debt Instrument [Line Items]
Exercise price at grant date (C$)	$ 13.47
November Notes
Debt Instrument [Line Items]
Exercise price at grant date (C$)	$ 980

Private Placement Notes - Sched

Private Placement Notes - Schedule of Private Placement Notes Payable (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Jan. 28, 2022	Oct. 06, 2021
Debt Instrument [Line Items]
Total private placement notes	$ 555,000	$ 555,000
Less: Unamortized debt discount & issuance costs	(10,534)	(13,336)
Less: current portion of private placement notes, net	(125,861)	0
Private placement notes, net	$ 418,605	541,664
Effective Interest Rate	10.77%
2026 Notes - Tranche One
Debt Instrument [Line Items]
Total private placement notes	$ 350,000	350,000
Stated Interest Rate	8%			8%
Effective Interest Rate	8.52%
Maturity Date	Oct. 06, 2026
2026 Notes - Tranche Two
Debt Instrument [Line Items]
Total private placement notes	$ 75,000	75,000
Stated Interest Rate	8%		8%
Effective Interest Rate	8.43%
Maturity Date	Oct. 06, 2026
June Notes
Debt Instrument [Line Items]
Total private placement notes	$ 70,000	70,000
Stated Interest Rate	9.75%
Effective Interest Rate	13.32%
Maturity Date	Jun. 11, 2024
November Notes
Debt Instrument [Line Items]
Total private placement notes	$ 60,000	$ 60,000
Stated Interest Rate	9.75%
Effective Interest Rate	13.43%
Maturity Date	Jun. 11, 2024

Private Placement Notes - Summa

Private Placement Notes - Summary of Scheduled Maturities of Principal Portion of Private Placement Notes Outstanding (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
2024	$ 130,000
2026	425,000
Total private placement notes	$ 555,000	$ 555,000

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2023
Lessee, Lease, Description [Line Items]
Loss on disposal of right of use assets		$ 10.5
Minimum
Lessee, Lease, Description [Line Items]
Lease term			8 years
Maximum
Lessee, Lease, Description [Line Items]
Lease term			9 years
Loss on disposal of right of use assets	$ 0.1
Real Estate Assets | Minimum
Lessee, Lease, Description [Line Items]
Lease term			5 years
Real Estate Assets | Maximum
Lessee, Lease, Description [Line Items]
Lease term			10 years
Other Leased Assets | Minimum
Lessee, Lease, Description [Line Items]
Lease term			3 years
Other Leased Assets | Maximum
Lessee, Lease, Description [Line Items]
Lease term			5 years
New Lease Agreement [Member]
Lessee, Lease, Description [Line Items]
Maximum exposure estimated contractual obligation			$ 5.8
New Lease Agreement [Member] | Minimum
Lessee, Lease, Description [Line Items]
Undiscounted future minimum lease payments			2.5
New Lease Agreement [Member] | Maximum
Lessee, Lease, Description [Line Items]
Potential additional payments under contractual obligation			$ 3.3

Leases - Components of Lease Co

Leases - Components of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Finance lease cost:
Finance lease cost	$ 4,191	$ 4,149	$ 8,574	$ 8,042
Total lease cost	12,096	11,698	23,859	23,068
Cost of Goods Sold, Sales and Marketing, General and Administrative
Lessee, Lease, Description [Line Items]
Operating lease cost	5,289	5,515	10,200	10,979
Finance lease cost:
Variable lease cost	2,450	1,878	4,716	3,792
Short term lease expense	166	156	369	255
Cost of Goods Sold and Depreciation and Amortization
Finance lease cost:
Amortization of lease assets	2,578	2,581	5,353	4,986
Interest Expense
Finance lease cost:
Interest on lease liabilities	$ 1,613	$ 1,568	$ 3,221	$ 3,056

Leases - Summary of Other Infor

Leases - Summary of Other Information Related to Operating and Finance Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Leases [Abstract]
Operating cash flows from operating leases	$ 5,005	$ 5,271	$ 10,067	$ 10,166
Operating cash flows from finance leases	1,612	1,559	3,267	3,047
Financing cash flows from finance leases	1,748	1,721	3,671	3,075
Operating leases, lease assets obtained in exchange for new lease liabilities	6,406	2,404	11,008	11,970
Finance leases, lease assets obtained and modified in exchange for new lease liabilities	$ 173	$ 12,112	$ 116	$ 18,413
Operating leases, weighted average discount rate	10%		10%		9.29%
Finance leases, weighted average discount rate	9%		9%		8.66%
Operating leases, weighted average remaining lease term (in years)	9 years 1 month 6 days		9 years 1 month 6 days		8 years 3 months 18 days
Finance leases, weighted average remaining lease term (in years)	7 years 8 months 12 days		7 years 8 months 12 days		7 years 9 months 18 days

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments under Non-cancellable Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Operating Lease
Six months ending December 31, 2023	$ 9,719
2024	20,420
2025	20,359
2026	19,708
2027	19,103
Thereafter	75,826
Total undiscounted lease liabilities	165,135
Less: Interest	(54,736)
Total related parties lease liabilities	110,399
Operating lease liabilities - current portion	(9,668)	$ (10,344)
Operating lease liabilities	100,731	100,531
Finance Lease
Six months ending December 31, 2023	6,831
2024	13,680
2025	13,470
2026	12,605
2027	11,703
Thereafter	43,358
Total undiscounted lease liabilities	101,647
Less: Interest	(29,436)
Total present value of minimum lease payments	72,211
Finance lease liabilities - current portion	(7,595)	(8,271)
Finance lease liabilities	$ 64,616	$ 69,948

Construction Finance Liabilit_3

Construction Finance Liabilities - Additional Information (Details) $ in Millions	1 Months Ended		3 Months Ended			6 Months Ended		12 Months Ended
	Oct. 31, 2021 USD ($) Option	Oct. 31, 2019 USD ($) Option	Jun. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Construction Finance Liability [Line Items]
Loss on disposal of long-lived assets						$ 45.8
Construction finance liability interest expense			$ 4.1		$ 3.9	8.2	$ 7.7
Hancock
Construction Finance Liability [Line Items]
Tenant improvements allowance	$ 12.9
Tenant improvements allowance received						12.3		$ 12.3
Finance lease liability, initial term	10 years
Finance lease liability, extended term	5 years
Number of options to extend finance lease | Option	2
Construction finance liability			19.1			$ 19.1		19.7
Lessee finance lease, option to extend						options to extend the term, the first providing a ten-year renewal option and the second providing a five-year renewal option.
Florida
Construction Finance Liability [Line Items]
Proceeds from sale of property		$ 17
Construction finance liability			17.8			$ 17.8		17.7
Pennsylvania
Construction Finance Liability [Line Items]
Finance lease liability, initial term		15 years
Finance lease liability, extended term		5 years
Number of options to extend finance lease | Option		2
Construction finance liability			42.1			42.1		41.8
Alachua
Construction Finance Liability [Line Items]
Finance lease liability, initial term	20 years
Finance lease liability, extended term	5 years
Number of options to extend finance lease | Option	2
Construction finance liability			$ 59.2			$ 59.2		$ 59.2
Loss on disposal of long-lived assets				$ (42.4)

Construction Finance Liabilit_4

Construction Finance Liabilities - Schedule of Future minimum Lease Payments for Construction Finance Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Construction Finance Liability [Abstract]
Six months ending December 31, 2023	$ 8,325
2024	17,043
2025	17,521
2026	18,013
2027	18,519
Thereafter	302,424
Total future payments	381,845
Less: Interest	(243,582)
Total present value of minimum payments	138,263
Construction finance liabilities - current portion	(1,324)	$ (1,189)
Construction finance liabilities	$ 136,939	$ 137,144

Equity - Additional Information

Equity - Additional Information (Details) - USD ($) $ in Millions	1 Months Ended	6 Months Ended
	Oct. 31, 2021	Jun. 30, 2023
Class Of Stock [Line Items]
Share based compensation unvested options, unrecognized compensation cost		$ 2
Share based compensation unvested options, unrecognized compensation expense weighted average recognition period		7 months 9 days
RSUs
Class Of Stock [Line Items]
Share based compensation unvested options, unrecognized compensation cost		$ 4.8
Share based compensation unvested options, unrecognized compensation expense weighted average recognition period		7 months 28 days
Harvest Liability Warrants | Liability Warrants
Class Of Stock [Line Items]
Number of warrants acquired	1,679

Equity - Schedule of Number and

Equity - Schedule of Number and Weighted-average Exercise Prices and Remaining Contractual Life of Warrants (Details) - Liability Warrants - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Number of warrants, Outstanding, Beginning Balance	1,679
Number of Warrants, Expired	(1,679)
Number of warrants, Outstanding, Ending Balance		1,679
Weighted average exercise price, Beginning Balance	$ 1,125
Weighted average exercise price, Expired	$ 1,125
Weighted average exercise price, Ending Balance		$ 1,125
Weighted Average Remaining Contractual Life (Yrs), Outstanding and exercisable		3 months 21 days

Equity - Schedule of Share Base

Equity - Schedule of Share Based Compensation Arrangements by Share-Based Payment Award (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Share based compensation expense	$ (243)	$ 2,578	$ 537	$ 4,735
RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Share based compensation expense	718	3,125	2,339	5,532
Cost of Goods Sold
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Share based compensation expense	19	(56)	35	70
Cost of Goods Sold | RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Share based compensation expense	41	258	260	458
General and Administrative Expenses
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Share based compensation expense	(275)	2,195	469	3,936
General and Administrative Expenses | RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Share based compensation expense	601	2,567	1,920	4,462
Sales and Marketing
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Share based compensation expense	13	439	33	729
Sales and Marketing | RSUs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total Share based compensation expense	$ 76	$ 300	$ 159	$ 612

Equity - Schedule of Stock Opti

Equity - Schedule of Stock Option Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Number of Options Outstanding, Beginning balance	3,177,815
Number of options, Forfeited	(334,864)
Number of Options Outstanding, Ending balance	2,842,951	3,177,815
Number of options, Exercisable	2,222,348
Weighted average exercise price Outstanding, beginning balance	$ 25.96
Weighted average exercise price, Forfeited	30.29
Weighted average exercise price Outstanding, Ending balance	25.45	$ 25.96
Weighted average exercise price, Exercisable	$ 25.67
Weighted Average Remaining Contractual Life (Yrs) Outstanding	4 years 7 months 28 days	5 years 4 months 28 days
Weighted Average Remaining Contractual Life (Yrs), Exercisable	3 years 7 months 2 days

Equity - Schedule of Restricted

Equity - Schedule of Restricted Stock Units Activity (Details) - Restricted Stock Units	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of warrants, Outstanding, Beginning Balance | shares	720,707
Number of shares/warrants, Forfeited | shares	(102,064)
Number of warrants, Outstanding, Ending Balance | shares	618,643
Weighted average exercise price, Beginning Balance | $ / shares	$ 22.36
Weighted average price, Forfeited | $ / shares	23.03
Weighted average exercise price, Ending Balance | $ / shares	$ 22.21

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Reconciliation For Calculation Of Basic And Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Earnings Per Share [Abstract]
Net loss from continuing operations	$ (342,304)	$ (18,787)	$ (376,626)	$ (45,831)
Less: Net loss attributable to non-controlling interest	(2,353)	(1,530)	(3,337)	(2,037)
Net loss from continuing operations available to common shareholders of Trulieve Cannabis Corp.	(339,951)	(17,257)	(373,289)	(43,794)
Net loss from discontinued operations	(64,568)	(5,234)	(95,877)	(10,672)
Less: Net loss attributable to non-controlling interest	(670)	0	(1,193)	0
Net loss from discontinued operations excluding non-controlling interest	$ (63,898)	$ (5,234)	$ (94,684)	$ (10,672)
Weighted average number of common shares outstanding	189,054,359	187,174,176	188,976,834	187,124,886
Diluted weighted average number of common shares outstanding	189,054,359	187,174,176	188,976,834	187,124,886
Basic loss per share Continuing operations	$ (1.8)	$ (0.09)	$ (1.98)	$ (0.23)
Diluted loss per share Continuing operations	(1.8)	(0.09)	(1.98)	(0.23)
Basic loss per share Discontinued operations	(0.34)	(0.03)	(0.5)	(0.06)
Diluted loss per share Discontinued operations	$ (0.34)	$ (0.03)	$ (0.5)	$ (0.06)

Earnings Per Share - Schedule_2

Earnings Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share based awards	2,842,951	3,465,639	2,985,093	3,547,090
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share based awards	618,643	1,035,762	655,474	1,057,043
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Share based awards	9,496	767,500	93,444	2,201,764

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) - shares	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock, shares issued	185,987,512	185,987,512
Common stock, shares outstanding	185,987,512	185,987,512
Not Contractually Issuable Until 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Fully vested RSUs	2,900,000

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Expense and Effective Tax Rate (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
(Loss) Income before provision for income taxes	$ (308,277)	$ 26,455	$ (307,142)	$ 42,553
Provision for income taxes	$ 34,027	$ 45,242	$ 69,484	$ 88,384
Effective tax rate	(11.00%)	171%	(23.00%)	208%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 49.5	$ 41.8
Increase in uncertain tax positions	$ 7.7

Discontinued Operations - Summa

Discontinued Operations - Summary of Assets and Liabilities Associated with Discontinued Operations (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Assets associated with discontinued operations
Cash	$ 1,800	$ 5,700	$ 14,900	$ 4,000
Massachusetts and Nevada Operations | Disposed of by Sale
Assets associated with discontinued operations
Cash	1,835	5,702
Accounts receivable, net	2,744	2,936
Inventories, net	3,230	21,310
Income tax receivable	2,718	2,267
Prepaids expenses and other current assets	947	1,486
Deferred tax asset	0	766
Property and equipment, net	0	53,687
Right of use assets - operating, net	0	1,769
Right of use assets - finance, net	0	5,736
Intangible assets, net	0	27,849
Other assets	2,013	2,638
Total assets associated with discontinued operations	13,487	126,146
Liabilities associated with discontinued operations
Accounts payable and accrued liabilities	1,120	1,617
Deferred revenue	0	109
Operating lease liabilities - current portion	70	93
Finance lease liabilities - current portion	427	456
Construction finance liability - current portion	1,794	0
Operating lease liabilities	14,686	16,428
Finance lease liabilities	2,829	5,890
Construction finance liability	25,237	45,217
Other long-term liabilities	156	154
Total liabilities associated with discontinued operations	$ 46,319	$ 69,964

Discontinued Operations - Sum_2

Discontinued Operations - Summary of Income (Loss) from Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Other (expense) income:
Income tax (provision) benefit	$ (946)	$ 473	$ (439)	$ 1,299
Net loss from discontinued operations, net of tax (provision) benefit	(64,568)	(5,234)	(95,877)	(10,672)
Less: Net loss attributable to non-controlling interest from discontinued operations	(670)	0	(1,193)	0
Net loss from discontinued operations excluding non-controlling interest	(63,898)	(5,234)	(94,684)	(10,672)
Massachusetts and Nevada Operations | Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues, net of discounts	4,472	6,444	8,347	14,231
Cost of goods sold	22,872	7,663	26,972	17,155
Gross margin	(18,400)	(1,219)	(18,625)	(2,924)
Expenses:
Operating expenses	1,994	2,984	4,382	6,049
Impairment and disposal of long-lived assets, net	41,639	0	69,275	0
Total Expenses	43,633	2,984	73,657	6,049
Income (Loss) from operations	(62,033)	(4,203)	(92,282)	(8,973)
Other (expense) income:
Interest expense	(1,589)	(1,534)	(3,178)	(3,058)
Other income, net	0	30	22	60
Total other expense, net	(1,589)	(1,504)	(3,156)	(2,998)
Loss before provision for income taxes	(63,622)	(5,707)	(95,438)	(11,971)
Income tax (provision) benefit	(946)	473	(439)	1,299
Net loss from discontinued operations, net of tax (provision) benefit	(64,568)	(5,234)	(95,877)	(10,672)
Less: Net loss attributable to non-controlling interest from discontinued operations	(670)	0	(1,193)	0
Net loss from discontinued operations excluding non-controlling interest	$ (63,898)	$ (5,234)	$ (94,684)	$ (10,672)

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Details) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain (loss) on extinguishment on result of lease reassessment	$ 18.5
Loss on disposal of related property and improvements	$ 45.8
Massachusetts
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Finance lease liability, initial term	10 years
Finance lease liability, extended term	1 year
Finance lease liability, expiration date	Dec. 31, 2030

Discontinued Operations - Sum_3

Discontinued Operations - Summary of Depreciation, Amortization, Loss on Impairment of Long-lived Assets, and Capital Expenditures of Discontinued Operations (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Other noncash investing and financing activities
Noncash partial extinguishment of construction finance liability	$ 18,486
Massachusetts and Nevada Operations | Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation	2,917	$ 2,875
Amortization	535	2,795
Purchases of property plant and equipment	67	685
Loss on impairment of long-lived assets	69,275	0
Other noncash investing and financing activities
Noncash partial extinguishment of construction finance liability	$ 18,486	$ 0

Discontinued Operations - Sched

Discontinued Operations - Schedule of Future minimum Lease Payments for Construction Finance Liability (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Six months ending December 31, 2023	$ 8,325
2024	17,043
2025	17,521
2026	18,013
2027	18,519
Thereafter	302,424
Total future payments	381,845
Less: Interest	(243,582)
Total present value of minimum payments	138,263
Construction finance liability - current portion	(1,324)	$ (1,189)
Construction finance liability	136,939	$ 137,144
Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Six months ending December 31, 2023	2,682
2024	5,455
2025	5,619
2026	5,788
2027	5,961
Thereafter	18,427
Total future payments	43,932
Less: Interest	(16,901)
Total present value of minimum payments	27,031
Construction finance liability - current portion	(1,794)
Construction finance liability	$ 25,237

Variable Interest Entities - Ad

Variable Interest Entities - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Variable Interest Entity [Line Items]
Loss on impairment and disposal of long-lived assets, net	$ 3,310		$ 5,055	$ 6,689	$ 21,516
Variable Interest Entities
Variable Interest Entity [Line Items]
Cash	800	$ 400
Business combination consideration transferred equity interests issued and issuable	1,700	$ 1,700
Loss on impairment and disposal of long-lived assets, net	800
Loss on deconsolidation of variable interest entity	10,000			10,000
Minority ownership interest received cash	$ 1,800			$ 1,800
Maximum
Variable Interest Entity [Line Items]
Ownership interests				95%
Minimum
Variable Interest Entity [Line Items]
Ownership interests				46%

Variable Interest Entities - Su

Variable Interest Entities - Summary of Assets and Liabilities of Company's VIEs (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current Assets:
Accounts receivable, net	$ 7,013	$ 6,507
Inventories, net	252,785	276,505
Prepaid and other current assets	42,867	62,278
Total current assets	474,837	593,511
Property and equipment, net	708,655	743,260
Right of use assets - operating, net	98,654	99,610
Right of use assets - finance, net	62,876	70,495
Intangible assets, net	951,460	984,797
Other assets	14,427	12,768
TOTAL ASSETS	2,808,682	3,400,373
Current Liabilities:
Accounts payable and accrued liabilities	75,457	82,090
Notes payable - current portion	9,076	12,453
Income tax payable	0	49,790
Deferred revenue	5,784	9,393
Operating lease liability - current portion	9,668	10,344
Finance lease liabilities - current portion	7,595	8,271
Total current liabilities	240,587	210,470
Notes payable, net	92,958	94,247
Operating lease liability	100,731	100,531
Finance lease liability	64,616	69,948
Deferred tax liabilities	211,901	224,696
Other long-term liabilities	37,424	26,027
TOTAL LIABILITIES	1,346,669	1,472,669
Variable Interest Entity, Primary Beneficiary
Current Assets:
Cash	6,703	7,349
Accounts receivable, net	1,208	597
Inventories, net	8,359	7,590
Prepaid and other current assets	514	46
Total current assets	16,784	15,582
Property and equipment, net	27,923	25,994
Right of use assets - operating, net	2,817
Right of use assets - finance, net	275	224
Intangible assets, net	17,830	17,947
Other assets	147	344
TOTAL ASSETS	65,776	60,091
Current Liabilities:
Accounts payable and accrued liabilities	2,188	3,713
Income tax payable	2,538	1,615
Deferred revenue	1	6
Finance lease liabilities - current portion	55	41
Total current liabilities	4,782	5,375
Notes payable, net	1,045	1,200
Operating lease liability	2,892
Finance lease liability	229	185
Deferred tax liabilities	3,663	4,101
Other long-term liabilities	796	625
TOTAL LIABILITIES	$ 13,407	$ 11,486

Related Parties - Additional In

Related Parties - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Related Party Transaction [Line Items]
Expenses recognized for related party leases	$ 0.1	$ 0.1	$ 0.1	$ 0.1

Related Parties - Right of Use

Related Parties - Right of Use Assets and Lease Liabilities under ASC 842 (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Operating
Right-of-use asset, net	$ 98,654	$ 99,610
Lease liabilities - current portion	9,668	10,344
Operating lease liabilities	100,731	100,531
Total related parties lease liabilities	110,399
Various Related Parties
Operating
Right-of-use asset, net	755	820
Lease liabilities - current portion	121	113
Operating lease liabilities	679	751
Total related parties lease liabilities	$ 800	$ 864

Revenue Disaggregation - Schedu

Revenue Disaggregation - Schedule of Net Revenues Comprised (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue, net	$ 281,795	$ 313,839	$ 567,009	$ 624,400
Retail
Disaggregation of Revenue [Line Items]
Revenue, net	271,888	297,603	546,733	587,645
Wholesale, Licensing and Other
Disaggregation of Revenue [Line Items]
Revenue, net	$ 9,907	$ 16,236	$ 20,276	$ 36,755

Commitments And Contingencies -

Commitments And Contingencies - Additional Information (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Loss Contingencies [Line Items]
Estimates related to various sales tax	$ 0.8
Contingent Liabilities
Loss Contingencies [Line Items]
Estimates related to various sales tax		$ 3
Pending Litigation | Contingent Liabilities
Loss Contingencies [Line Items]
Contingent liabilities	$ 1.6	$ 31.7

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - Subsequent Events - 2021 Omnibus Incentive Plan - Certain Employees and Directors	1 Months Ended
	Jul. 31, 2023 shares
Subsequent Event [Line Items]
Stock options granted	1,754,817
Stock Options | Maximum
Subsequent Event [Line Items]
Vesting period	3 years
Restricted Share Units
Subsequent Event [Line Items]
Restricted share units granted	3,017,294
Restricted Share Units | Maximum
Subsequent Event [Line Items]
Vesting period	3 years